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Abstract 
Sufferers of Post-Traumatic Stress Disorder (PTSD) caused by repeated or 
prolonged traumas, such as childhood abuse or intimate partner violence, may have 
symptoms that go beyond the normal clusters of symptoms seen in PTSD from single-
incident traumas. These can include emotional, interpersonal, dissociative and somatic 
symptoms, and altered beliefs about the self, others and the world. This has been 
termed Complex Post-Traumatic Stress Disorder (CPTSD). Recent expert guidelines 
recommend that treatment for CPTSD should consist of several phases, not only 
individual trauma-focused therapy.  
This study is the first evaluation of a new phase-based treatment programme 
for CPTSD, consisting, sequentially, of a psychoeducation group (Phase 1), 
Compassionate Resilience group (CRG; Phase 2), and individual trauma-focused 
therapy (Phase 3). The main research questions were: how effective is the treatment in 
addressing both PTSD and CPTSD symptoms; and secondly, how acceptable is the 
treatment to participants?  
The study had two components: firstly, a case series analysis of nine 
participants examining the effectiveness of the treatment, using measures of PTSD, 
CPTSD and self-compassion. The second component was a thematic analysis of 
interviews with six participants who had completed treatment, in order to explore the 
acceptability of the programme.  
Results from the case series analysis indicated that the treatment was effective 
in reducing CPTSD, PTSD symptoms, and self-criticism.  As predicted, visual 
analysis of symptom scores suggested greater symptom improvement during Phase 2 
3 
 
than Phase 1. Surprisingly, PTSD symptoms improved before Phase 3, with three 
participants showing clinically-significant improvement by the end of Phase 2. The 
thematic analysis indicated the treatment was highly acceptable to participants, with 
over-arching themes identified regarding the experience of group format and 
experience of phase-based treatment. 
Overall, this study appeared to support the use of phase-based treatments for 
CPTSD, and indicated that compassion-focused interventions may be an effective 
component therein.  
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Chapter 1: Introduction 
 “Something was wrong. They put on civilian clothes again and looked to their 
mothers and wives very much like the young men who had gone to business in 
the peaceful days before August 1914. But they had not come back the same 
men. Something had altered in them. They were subject to sudden moods, and 
queer tempers, fits of profound depression alternating with a restless desire 
for pleasure. Many were easily moved to passion where they lost control of 
themselves, many were bitter in their speech, violent in opinion, frightening.” 
 (War correspondent Sir Philip Gibbs, ‘Realities of War’, London: 
Heinemann, 1920) 
 
The psychological impact of experiencing or witnessing a traumatic event 
such as war, rape, fire or assault is recognised and understood today to a degree that 
would have been unimaginable a century ago. British soldiers in the First World War 
suffering ‘shell shock’, a condition initially attributed to nerve damage and later 
understood as a psychological response to the stresses of war, were often treated with 
ignominy and in some cases put on trial for cowardice or desertion. The returning 
soldiers for whom “something had altered” were faced by an almost total lack of 
understanding of their symptoms or consensus about how to treat them. The term 
‘post-traumatic stress disorder’ (PTSD) did not come into use until the 1970s, when 
the phenomenon was brought to medical attention by US military veterans of the 
Vietnam War. PTSD was only officially recognised as a psychiatric diagnosis by the 
American Psychiatric Association in 1980, and included in the International 
Classification of Diseases (ICD) in 1990.   
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Today, PTSD is widely recognised as a serious psychological disorder that can 
result from any kind of trauma, not simply those occurring in war, and for which, 
happily, effective psychological treatments (most commonly trauma-focused 
Cognitive Behavioural Therapy (CBT), and Eye Movement Desensitisation and 
Reprocessing, EMDR) have been developed.  However, less widely accepted is the 
argument that there is a sub-group of people with PTSD for whom the effects of 
trauma are more far-reaching, and for whom existing PTSD treatments may not be 
sufficient. For this group, the experience of trauma impacts on the person’s sense of 
self, their capacity to know and accept themselves, to keep themselves safe, and to 
relate to and trust others. This more complicated reaction to trauma has been termed 
Complex Post-Traumatic Stress Disorder (CPTSD), and has been linked in particular 
to the experience of repeated interpersonal traumas such as childhood physical or 
sexual abuse, intimate partner violence (IPV), human trafficking, slavery or being a 
prisoner of war. 
Academic disagreement over the validity and utility of separating CPTSD 
from PTSD has meant that the large-scale research studies and evidence-based 
treatment protocols that are plentiful in the area of PTSD are relatively scarce for 
CPTSD.  This study sought to investigate the effectiveness of one new treatment 
approach designed to address this gap, and in so doing, contribute to a better 
understanding of ‘what works’ for this less well understood, highly traumatised 
population.  
Before describing the current study, we begin with an overview of the research 
literature, starting with the debate around the diagnostic status of CPTSD, and 
whether or not CPTSD merits a different treatment approach to PTSD. Arguments for 
12 
 
and against phase-based treatment protocols are then explored, and outcome studies of 
existing treatment protocols are evaluated. This provides the context for the current 
study, which evaluated the effectiveness and the acceptability of a new phase-based 
treatment for CPTSD. Effectiveness was evaluated through a small case series of 
patient outcome data collected longitudinally throughout treatment. Acceptability was 
evaluated through interviews with participants at the end of treatment, analysed 
qualitatively to identify important themes in their experiences of the treatment.  
Diagnostic Status of CPTSD 
The term CPTSD and its position in relation to the diagnosis of PTSD is 
highly contested in the clinical and research literature. PTSD diagnostic criteria 
include: avoidance of reminders or memories of the trauma; re-experiencing 
symptoms such as dreams or flashbacks, negative cognitions and mood; and arousal 
symptoms such as hypervigilance to threat and insomnia. The traumatic event must 
involve direct or indirect exposure (through family or friends) or witnessing: death, 
threatened death, actual or threatened serious injury, or actual or threatened sexual 
violence (Diagnostic and Statistical Manual of Mental Disorders [DSM-V]; American 
Psychiatric Association, 1994). The most recent criteria also include a ‘dissociative 
subtype’ of PTSD.   
Complex post-traumatic stress disorder (CPTSD) is a term used to describe a 
constellation of difficulties in addition to the above-mentioned symptoms of PTSD. 
Authors who support its differentiation from PTSD broadly agree that it is 
differentiated from the core symptoms of PTSD by five additional symptom domains 
(Cloître et al., 2012). These include: 1) chronic difficulties with regulating emotions, 
2) difficulties with relationships, 3) alterations in consciousness (e.g. dissociation), 4) 
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adversely affected belief systems including changes in self-concept (e.g. shame, guilt) 
or loss of previously-valued beliefs; and 5) somatisation of distress in medically 
unexplained physical symptoms.  Those that do not support the differentiation of 
complex from ‘simple’ PTSD argue that a diagnosis of CPTSD lacks sufficient 
discriminant validity, and some also cite a lack of agreement in research about its core 
features and its precipitating factors (Resick et al., 2012).  
  The disagreement in academic PTSD research about whether there is 
sufficient evidence to warrant treating CPTSD as a separate diagnosis to PTSD is 
reflected in the differing stances taken by the Diagnostic and Statistical Manual of 
Mental Disorders (DSM) and the International Classification of Diseases (ICD).  
Whilst there is no separate diagnostic category for CPTSD in DSM-V (American 
Psychiatric Association, 2013), the ICD-10 (World Health Organisation [WHO], 
1992) includes a diagnosis of ‘personality change after a catastrophic event’ which 
partly reflects the concept of CPTSD.  In current proposals for the updated ICD-11 
there are two separates diagnoses: PTSD and CPTSD, both of which sit within the 
spectrum of trauma and stress-related disorders. This proposed diagnosis of CPTSD is 
comprised of the core elements of PTSD accompanied by enduring disturbances in the 
domains of affect, self, and interpersonal relationships (Maercker et al., 2013).  
Origins of CPTSD  
The term ‘Complex post-traumatic stress disorder’ was first proposed by 
Judith Herman in ‘Trauma and Recovery’ (1992). Herman argued that the diagnosis 
of PTSD does not accurately fit the syndrome seen in survivors of prolonged or 
repeated traumas. She argued for treating responses to traumas as a ‘spectrum of 
conditions’ rather than a single diagnosis, and in particular argued for separate 
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recognition of a syndrome she called CPTSD that results from ‘a history of subjection 
to totalitarian control’, ranging from military control, such as being kidnapped, taken 
hostage, to domestic or sexual control such as chronic child or spousal abuse. Herman 
claimed that being subject to this type of prolonged traumatisation leads to alterations 
in a number of important domains: affect regulation, consciousness, self-perception, 
perception of the perpetrator, relations with others, and systems of meaning (Herman, 
1992).  
Herman proposed that treatment for people with CPTSD ought to consist of 
three stages, the first of which should focus on regaining personal safety and stability, 
the second on directly working with the traumatic memories and reconstructing the 
story, and the third on restoring the connection between the survivor and his or her 
community, with a view to building a richer post-trauma life.  
Although Herman was the first to use the term CPTSD, her research added to 
ideas that had already been proposed by researchers in areas such as the mental health 
of refugees (Kroll et al., 1989), childhood traumas (Terr, 1991) and childhood sexual 
abuse (Finkelhor, 1988), all of whom argued that the standard PTSD diagnosis was 
inadequate to describe the multiplicity of psychological effects and functional 
impairments seen in clinical practice in survivors who have experienced prolonged 
traumas.  
As a consequence of this interest in PTSD to repeated traumas, a field trial 
was conducted for the fourth edition of the Diagnostic and Statistical Manual of 
Mental Disorders (DSM-IV; American Psychiatric Association, 1994) testing the 
existence of a disorder termed ‘Disorders of stress not otherwise specified’ 
(DESNOS), which had close similarities to Herman’s proposed CPTSD. The 
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conclusions of this trial were that DESNOS did not merit a separate diagnosis because 
most people who met criteria for it also met criteria for PTSD; however, DESNOS 
was listed amongst ‘associated features’ of PTSD with many of the listed features 
taken from Herman’s formulation of CPTSD (Weiner, 2003).  
The DESNOS diagnosis had six main features: alterations in the regulation of 
affective impulses, including anger and self-destructive impulses; alterations in 
attention and consciousness leading to amnesia, dissociative episodes and 
depersonalisation; alterations in self-perception such as chronic guilt, shame and 
responsibility; alterations in relationships with others, such as not being able to feel 
intimate, or trust; somatisation that cannot be medically explained; and alterations in, 
or loss of, sustaining beliefs (Luxenberg, Spinazzola & Van der Kolk, 2001).   
In the recently-published DSM-V, DESNOS was removed and at the same 
time PTSD was no longer classified as an anxiety disorder but as part of a new 
diagnostic category of “Trauma and Stressor-Related Disorders” incorporating acute 
stress disorder, adjustment disorders, and others (American Psychiatric Association, 
2013).  
CPTSD: A Separate Diagnosis? 
 During the development of DSM-V the question of whether CPTSD ought to 
feature separately was revisited in some depth. In order to make recommendations to 
the committee, Resick et al. (2012) conducted a critical evaluation of all the available 
research studies of adult samples.  They included studies using the terms ‘CPTSD’, 
‘complex trauma’, ‘DESNOS’, ‘post-traumatic personality disorder’ and ‘personality 
change after a catastrophic event’. Evaluating these studies, the authors concluded 
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that there are several difficulties with establishing CPTSD as a separate diagnosis: 
firstly, a lack of agreement about the types of traumatic events that precipitate it, and 
about the core symptoms of the disorder; secondly, that CPTSD lacks discriminant 
validity by overlapping significantly with PTSD, as well as borderline personality 
disorder (BPD) and major depressive disorder (MDD).  Resick and colleagues did 
acknowledge that a single diagnosis of PTSD cannot adequately capture the 
heterogeneity of adaptation and distress that occurs following trauma exposure. 
However, they concluded that the available evidence does not sufficiently 
demonstrate the construct validity of CPTSD to justify a new diagnosis (Resick et al., 
2012). 
There is, however, conflicting evidence regarding the discriminatory validity 
of a CPTSD diagnosis.  An important piece of evidence supporting a separate 
diagnosis from ‘simple’ PTSD has been offered by a latent profile analysis of 302 
people seeking treatment for interpersonal trauma, including both single incident and 
chronic trauma, conducted by Cloître, Garvert, Brewin, Bryant and Maercker (2013). 
Their analysis indicated that there are in fact classes of individuals that are 
distinguishable according to different PTSD and CPTSD symptom profiles. The 
‘CPTSD’ class identified in the latent profile analysis had high levels of symptoms in 
PTSD, affect dysregulation, negative self-concept, and interpersonal problems. By 
contrast the ‘PTSD’ class had high levels of PTSD symptoms but relatively low levels 
of symptoms in the three self-organisation domains. The analysis also showed that 
CPTSD was associated with greater overall impairment than PTSD.  Additionally, the 
analysis indicated that chronic trauma was more strongly predictive of CPTSD than 
PTSD, whilst single-event trauma was more strongly predictive of PTSD.  
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Regarding CPTSD and BPD, the overlap between these symptom profiles has 
been widely noted in research and clinical practice; both incorporate difficulties with 
relationships, emotional instability, and dissociative symptoms. They are also both 
theorised to have their origins in traumatic (usually early) experiences. However, 
Cloître, Garvert, Weiss, Carlson & Bryant (2014) conducted a latent profile analysis 
which indicated that an independent CPTSD symptom profile can be distinguished 
from that of both PTSD and BPD. The best fit model identified by their analysis was a 
four class model which they labelled as ‘low symptoms’, ‘PTSD’, ‘CPTSD’ and 
‘BPD’ class.  The participants in the CPTSD class were high in self-organisation 
symptoms and PTSD symptoms, but relatively low in BPD symptoms. The authors 
noted that some symptoms in the BPD class were not seen in the CPTSD class, such 
as frantic efforts to avoid abandonment, alternating between extremes of idealisation 
and devaluation in personal relationships, persistently unstable sense of self, and 
impulsiveness.   
Ford and Courtois (2014) also argue that CPTSD should be treated as a 
separate diagnosis to BPD.  They reviewed the clinical and scientific findings of 
comorbidity between CPTSD, PTSD and BPD in detail, considering the 
neuropsychological features of each disorder and drawing on evidence from neuro-
imaging studies. Whilst they emphasise the preliminary nature of their findings, the 
authors conclude that the available research indicates that emotional dysregulation in 
BPD involves brain alterations associated with deficient self-awareness, intolerance of 
interpersonal rejection or abandonment, inability to recover from intense negative 
affect states, and dissociative analgesia. By contrast, PTSD secondary to childhood 
maltreatment, which is treated as a proxy for CPTSD, seems to involve brain 
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alterations associated with heightened self-awareness of vulnerability, hypervigilance 
to safety threats and related threat appraisals, tolerance of chronic negative affect 
states, and dissociative re-experiencing with alternating states of fear and detachment 
(Fort & Courtois, 2014). Taken together with the two latent profile analyses of Cloître 
and colleagues (2013; 2014), there does appear to be a growing body of evidence of 
the utility of differentiating CPTSD from both PTSD and from BPD.  
Do People with CPTSD need Different Treatment to People with PTSD?  
At present in the UK there are national clinical guidelines for treatment of 
PTSD provided by the National Institute for Health and Care Excellence (NICE), 
which recommend trauma-focused psychological treatment of normally eight to 12 
sessions. There are no specific guidelines for treatment of CPTSD.  However, the 
PTSD guidelines do recommend that healthcare professionals should consider 
extending the duration of treatment beyond 12 sessions if several problems need to be 
addressed, and particularly after multiple traumatic events. They also recommend that 
where patients find it very difficult to trust their clinician with details of their 
trauma(s), treatment should begin with establishing a trusting therapeutic relationship 
and emotional stabilisation before addressing the traumatic event (NICE, 2005). 
However, they do not give any more detail about the nature of this treatment, or make 
specific reference to the treatment of CPTSD. 
The absence of a broadly agreed, independent diagnosis of CPTSD is likely to 
be a major factor in the absence of specific protocols for treatment of CPTSD. As a 
result, most people with CPTSD symptom profiles are at present receiving treatment 
that is not specifically designed to tackle the extra symptom dimensions of CPTSD; 
however, there is a lack of agreement in the literature about whether or not this is 
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problematic.  To date there are only a few studies comparing treatment outcomes for 
PTSD and CPTSD populations.  
There is some limited evidence that suggests that people with prolonged or 
repeated trauma histories may be effectively treated through stand-alone trauma-
focused treatment protocols for PTSD, without specific adjuncts to treat CPTSD 
symptoms. Resick, Nishith and Griffin (2003) conducted a randomised controlled trial 
(RCT) of a treatment called cognitive processing therapy (CPT) lasting twelve 
sessions, which incorporates both cognitive therapy and exposure through writing and 
reading about the traumatic event. In this trial of treatment of survivors of childhood 
sexual abuse (CSA) the authors concluded that CPT was effective in treating the 
symptoms of CPTSD, as measured by the Trauma Symptom Inventory (TSI), as well 
as PTSD and depression symptoms, with participants showing significant 
improvements that were maintained over 9 months. Improvements were seen not just 
in core PTSD and depression symptoms but also in symptoms such as dissociation, 
impaired self-reference, dysfunctional sexual behaviour, and tension-reduction 
behaviours.  Whilst this indicates that this type of trauma-focused CBT can be 
effective for some people with CPTSD, it does not preclude the possibility that this 
population might show greater improvements using another treatment approach, nor 
has it yet been evidenced in other CPTSD populations. Furthermore, the TSI was not 
designed to assess CPTSD and therefore does not probe all five additional symptom 
dimensions.  
In contrast, there is research which points to limitations of using PTSD 
protocols to treat people with CPTSD symptom profiles. In a study by Ford and Kidd 
(1998) of war veterans receiving inpatient treatment for chronic PTSD, DESNOS 
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symptom profiles emerged as a consistent and robust predictor of poor inpatient 
PTSD treatment outcome, independent of the effects of a PTSD diagnosis or of early 
childhood trauma history.  Whereas a PTSD diagnosis predicted an increased 
likelihood of clinically-meaningful change in this study, DESNOS symptoms 
predicted a substantially decreased likelihood of clinically meaningful change. 
Similarly, Ehlers et al. (1998), Ford and Kidd (1998), Tarrier et al. (1999) and van der 
Kolk et al. (2007) have all published studies that indicate that trauma-focused 
treatment may be less efficacious and less well tolerated in CPTSD populations.  
A specific area of debate is the impact of exposure-only therapy on drop-out 
rates amongst CPTSD populations.  Drop-out rates for exposure-based PTSD 
treatment can be particularly high amongst CPTSD populations, as demonstrated by a 
study by McDonagh et al. (2005) of women with histories of CSA. The authors found 
that women who received a standard CBT protocol for PTSD had a drop-out rate of 
41.4 per cent.  A further finding was that the drop-out rate was significantly higher for 
participants receiving exposure therapy than for participants receiving a present-
centred problem-solving therapy, which the authors suggest may indicate that women 
with more complex presentations have difficulty tolerating exposure work due to 
cognitive and affect-regulation problems (McDonagh et al, 2005).  By contrast, 
however, a meta-analysis by Hembree et al. (2003) of studies of psychological 
therapies for PTSD found an average drop-out rate of 20.5 per cent in exposure 
treatments and 26.9 per cent for treatments combining exposure therapy with other 
CBT techniques, suggesting that it may be in fact be counterproductive to add extra 
components to exposure treatment protocols, in terms of adherence of treatment.  
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Whilst there are insufficient robust outcome studies of treatment for CPTSD 
populations to be able to draw definite conclusions about their efficacy, the research 
that exists does suggest that the presence of CPTSD symptoms ought to be carefully 
considered in treatment planning (Weiner, 2003). This research has led to clinicians 
and researchers looking to adapt standard PTSD protocols and develop new treatment 
protocols for CPTSD, many of which have taken a phase-based approach.  
Why Phase-based Treatment? 
 In 2012 a Complex Trauma Taskforce made up of PTSD experts, created by 
the International Society for Traumatic Stress Studies (ISTSS), carried out a survey of 
50 expert clinicians working with people with CPTSD. The aim was to survey 
opinions about the salient symptoms of CPTSD and recommendations for its 
treatment. As a result of the survey, expert consensus guidelines for the treatment of 
CPTSD in adults were published (Cloître et al., 2012). The guidelines state that 
treatment for CPTSD should build functional capacities for self-regulation and 
psychosocial resources through emotion regulation strategies, anxiety and stress 
management, and interpersonal skills. Deficits in these areas are a logical first step for 
intervention since they may interfere not only in daily functioning but also in the 
therapeutic process itself (Zlotnick et al., 1997).  The survey found that 84 per cent of 
the clinicians surveyed endorsed a phase-based approach to working with this 
population.  
In a recent meta-analysis of psychological treatments for PTSD in adult 
survivors of child abuse (PTSD related to child abuse is taken as a proxy for PTSD 
with complex symptoms, in the absence of an agreed diagnosis of CPTSD), Ehring et 
al. (2014) looked in detail at the eight existing trauma-focused CBT protocols for 
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individual treatment. They compared the four that were multi-component (Cloître, 
Koenen, Cohen, & Han, 2002; Chard, 2005; Cloître et al., 2010; Bohus et al., 2013) 
with the four that were purely trauma focused (McDonagh et al., 2005; Resick et al., 
2008 which includes three treatments), and found that effect sizes for the multi-
component treatments were larger (from 2.27 to 1.31) than the purely trauma-focused 
models (1.37 to 0.70), providing support for the utility of phase-based approaches in 
this population (Cloître, 2015).  
A challenge to the ISTSS’s conclusions was presented by a recent review of 
the evidence by de Jongh and colleagues (2016). In this paper the authors point to a 
lack of studies directly comparing the effectiveness of trauma-focused treatment with 
phase-based approaches, and to the high drop-out rates that complicate conclusions 
about intervention effects. They also question whether CPTSD normally entails 
emotional dysregulation, querying the necessity of stabilisation phases.  The authors 
conclude that there is currently insufficient evidence for the advantages of phase-
based treatments over trauma-focused therapy alone, and argue that an over-emphasis 
on phase-based treatment may unnecessarily delay sufferers’ access to treatment.   
A response to de Jongh and colleagues by Cloître (2016) argues that although 
rigorous evidence in favour of phase-based treatments over trauma-focused therapy 
alone is currently limited, the available studies showing positive outcomes, in 
combination with there being no evidence of phase-based treatments being harmful to 
engagement with trauma-focused therapy, provide a good case for continuing to 
research such treatments. Both de Jongh et al. (2016) and Cloître agree on the need 
for further, more rigorous research on phase-based treatments for CPTSD.  
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Even amongst researchers who support the use of phase-based treatments, 
there is a little consensus about the number of phases, their length, and what they 
ought to consist of. The treatment structure suggested by the ISTSS guidelines is a 
three-phase model where the first phase focuses on patient safety and then on building 
emotional awareness and expression, increasing positive self-concept, addressing 
feelings of guilt and shame, and increasing interpersonal and social competencies 
(Cloître et al, 2011).  The second suggested phase focuses on processing of trauma 
memories. The third is a phase in which the clinician supports the patient in making 
plans for greater engagement in community life through education, employment, 
social activities or hobbies, in order to support their transition out of therapy.  This is 
strongly reminiscent of Herman’s proposed model, in which the third phase of 
treatment aims to restore the connection between the survivor and his or her 
community in order to build a richer post-trauma life. 
Whilst there was broad agreement amongst the experts in the ISTSS survey on 
the use of phase-based treatments, there was little agreement on the expected course 
of treatment or the overall duration of treatment (Cloître et al., 2011). The proposed 
overall duration of treatment for patients with CPTSD ranged from four months to 
twelve months. This lack of agreement is attributed by the authors of the guidelines to 
the paucity of research studies exploring these variables, methodological variations 
across the studies, differences in samples in trauma background, and differences in 
measures used, all of which make generalisation difficult. The authors of the 
guidelines argue for more systematic research into phase-based approaches, 
evaluation of rates of change, and comparison studies of the individual components of 
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treatment (Cloître et al., 2012). The few existing studies of phase-based treatments for 
CPTSD will now be reviewed.   
Existing Phase-based Treatments for CPTSD 
An early and significant contribution to the field of phase-based treatment 
research was offered by a randomised clinical trial by Cloître, Koenan, Cohen and 
Han (2002). In this trial 58 women with PTSD related to childhood abuse were 
allocated to either a two-phase treatment called ‘STAIR-MPE’, or to a minimal 
attention wait list. In the treatment condition participants first received eight weekly 
one-to-one sessions of skills training in affect and interpersonal regulation (STAIR), 
then a second phase consisting of modified prolonged exposure (MPE) therapy. 
Although the participants were not assessed on CPTSD or DESNOS criteria, their 
childhood abuse trauma backgrounds made them more likely to have had symptom 
profiles consistent with such a diagnosis, and it was therefore used by the authors as a 
proxy for CPTSD.  
The results of Cloître et al.’s (2002) trial indicated two things of significance. 
Firstly, that the phase-based treatment condition outperformed the wait list condition 
in reducing PTSD symptoms and interpersonal skill deficits, and improving affect 
regulation. Secondly, that therapeutic alliance and negative mood regulation skills 
measured in Phase 1 predicted the success of exposure work in Phase 2 for reducing 
PTSD symptoms, demonstrating the value of building emotion regulation skills before 
commencing exposure work for improving the effectiveness of exposure therapy.  
A number of other manualised phase-based treatments have been developed, 
the majority of which adopt a group format for the initial phase.  A pilot study by 
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Dorrepaal et al. (2010) evaluated a manualised stabilising group treatment designed 
by Wolfsdorf and Zlotnick (2001) for the treatment of CPTSD originating from 
childhood abuse. The programme begins with psychoeducation about CPTSD before 
moving onto a cognitive behavioural approach to building skills in emotional 
regulation, relaxation, assertiveness and anger management, and concludes with work 
on distrust, guilt and shame.  The intervention, lasting 20 weeks, was designed to 
directly target the extra symptoms of CPTSD, and to then be followed by exposure 
therapy once tolerance of high affect has been achieved.  
Dorrepaal and colleagues’ analysis of 36 patients who had symptoms in all 
domains of CPTSD in this pilot project showed that, after the stabilising treatment, 64 
per cent of patients no longer met criteria for CPTSD, as measured by the Structured 
Clinical Interview for DSM-IV Axis I disorders (SCID-1; First, Spitzer, Gibbon & 
Williams, 1996) and the Structured Interview for Disorders of Extreme Stress 
(SIDES; Pelcovitz et al., 1997).  After 6 months, this figure rose to 78 per cent. 
However, there was a drop-out rate of 33 per cent from treatment.   Additional 
support for this intervention has been offered by an adjunctive neuro-imaging study 
which found that adding the stabilising treatment could be linked to increased 
selective attention ability and decreased emotional arousal, associated with 
normalised activation in the dorsal anterior cingulate cortex and anterior insula 
(Thomaes et al., 2012). 
In a later study of the same manualised intervention, Dorrepaal et al. (2013) 
found that the stabilisation group was well tolerated by participants with comorbid 
personality disorder symptoms, including both those with socially withdrawn 
personalities and those with aggressive traits. In fact, those with personality disorder 
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symptoms appeared to have a lower drop-out rate (10 per cent) than those without 
personality disorder symptoms (33 per cent), suggesting that stabilisation phases may 
be more appropriate for some presentations of CPTSD than others.    
A pilot of a brief eight-session psychoeducation group programme called 
‘Survive and Thrive’ with female offenders with complex trauma history evaluated by 
Ball, Karatzias, Mahoney, Ferguson and Pate (2013) also showed positive results. The 
researchers did not directly measure CPTSD symptomology, but did find medium to 
large treatment effect sizes indicating clinical improvement in general psychological 
distress as well as traumatic symptomology, as measured by the Clinical Outcomes in 
Routine Evaluation Outcome Measure (CORE-OM) and the PTSD Checklist Civilian 
version (PCL-C). The manualised programme covered topics including: the physical, 
emotional and psychological effects of trauma and abuse; coping strategies such as 
relaxation; developing emotional regulation skills, and dealing with substance misuse. 
However, there was a 46 per cent drop out before follow-up, some of whom dropped 
out due to acute problems needing treatment in own right, such as substance abuse.  
Theoretical Basis of Compassion-focused Interventions for PTSD 
Typically, PTSD treatment protocols have been oriented primarily towards 
alleviating fear, which is reflected in PTSD’s previous categorisation as an anxiety 
disorder in DSM-IV. Dominant theories of PTSD such as the Ehlers and Clark 
cognitive model (2000) have viewed PTSD symptoms as resulting from the 
fragmented, unprocessed nature of trauma memories combined with negative 
appraisals of the traumatic event, that together maintain a sense of current threat. The 
sense of threat leads to maladaptive coping strategies, such as avoidance of the trauma 
memory, that prevent alterations to the memory or the appraisals.  In treatment, the 
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current sense of threat is therefore targeted through cognitive work that seeks to 
process the trauma memory, alter the appraisals of the memory, and reduce 
maladaptive coping strategies. This cognitive, fear-based approach to PTSD provides 
the theoretical basis for the third phase of the treatment programme being evaluated in 
the current study.  
However, an alternative clinical model of PTSD has been proposed by Lee, 
Scragg and Turner (2001) which is based on shame and guilt, and this provides the 
theoretical basis for the second phase of the phase-based intervention, the 
Compassionate Resilience Group (CRG). Lee, Scragg and Turner argue that, whilst 
fear is often the primary emotional response to a trauma, other emotional responses, 
in particular shame and guilt, are also highly significant to the perpetuation of PTSD 
symptoms (2001). Shame is important because it may present clinically as shame 
attached to one’s actions or responses at the time of the trauma, as well as shame 
attached to the emotions experienced during therapy, such as intense fear or 
helplessness (Lee et al., 2001). Therefore, shame may also affect a person’s ability to 
engage in recovery-promoting behaviours, such as disclosing details of the trauma and 
engaging in exposure-based therapy. Research by Lee has suggested that the emotion 
of shame may be resistant to traditional cognitive restructuring (Lee, 2009) a 
technique commonly used in trauma-focused CBT for alleviating fear responses, and 
therefore requires an alternative therapeutic approach.  
   Lee advocates working to reduce shame and self-criticism in PTSD sufferers 
by drawing on a compassion-focused therapy (CFT) approach (Gilbert & Irons, 
2005). CFT was originally developed as an adjunct to cognitive therapy by Paul 
Gilbert (Gilbert, 2000).  It seeks to enhance the capacity to self-soothe and to reduce 
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self-critical maintenance cycles and feelings of shame by developing compassionate 
self-talk. Academic research into self-compassion has been led by Kristin Neff. Neff’s 
work defines self-compassion as consisting of three components: (a) an attitude of 
kindness and understanding to one’s self, as opposed to harsh judgment; (b) 
perceiving one’s experiences as part of the larger human condition instead of feeling 
separate and isolated; and (c) being mindfully aware of painful experiences without 
over-identifying with them (Neff, 2003a). Research has found that higher self-
compassion is associated with less depression, anxiety, rumination, and thought 
suppression, and with greater life satisfaction and social relatedness (Neff, 2003b). 
 Gilbert’s social mentality theory (2000) suggests that self-compassion may be 
particularly lacking in people who have often experienced early childhood abuse, as is 
the case for many people with CPTSD. The theory suggests that how we engage in 
social roles with our self and others is shaped by our experiences, and that unless a 
child’s processing systems for feeling cared for are stimulated and elaborated through 
experiences, they will not be available for use in ‘self-self’ relating (Gilbert & Irons, 
2005). This lack of capacity to relate compassionately with the self then results in 
lower resilience to psychological threats to self-integrity, such as shame and guilt.  
Evidential Basis for Compassion-focused Interventions in PTSD 
There is a small body of research that indicates links between deficits in self-
compassion and PTSD symptoms. Lee’s research in the area of CFT for PTSD has 
found that a significant number of people suffering from PTSD experience shame or 
are highly self-critical and lack the capacity to self-soothe (Lee, 2012).  Cox, 
MacPherson, Enns and McWilliams (2004) conducted research with a nationally-
representative sample of adults who had experienced traumatic events, and found that 
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higher self-criticism and neuroticism was associated with the presence of PTSD 
symptoms. Based on this research, Kearney et al. (2013) piloted a 12-week group 
intervention for veterans with PTSD, using ‘loving-kindness meditation’. This is a 
practice designed to enhance feelings of kindness and compassion for self and others. 
The authors found a large effect size (−0.89) for PTSD symptoms at 3-month follow-
up.  
Although there is only limited evidence so far for self-compassion 
interventions for PTSD, the available evidence suggests that self-compassion may be 
a helpful approach. It follows that it may be particularly useful for those with the 
additional symptoms of CPTSD such as alterations in belief systems, which often 
includes changes in self-concept such as shame, guilt and responsibility beliefs.  
Lee’s Compassionate Resilience group intervention (CRG), based on CFT 
principles, has been developed in order to target CPTSD symptoms. CRG aims to 
enhance affect regulation, self-soothing, interpersonal functioning, problem-solving 
and the ability to hold trauma memories with a caring, compassionate mind. It 
constitutes the second phase of the treatment protocol which is evaluated in the 
present study, coming after an initial psychoeducation phase about PTSD and its 
effects (Phase 1), and before a final phase of individual trauma-focused therapy 
(Phase 3).  This phase-based treatment programme is currently the only phase-based 
treatment for CPTSD to incorporate a discrete phase of compassionate resilience 
work.  
Although no trial has yet tested the effectiveness of compassion-focused 
therapy in a CPTSD population, CFT has been used successfully as an adjunctive 
treatment for a range of other psychological disorders, including eating disorders 
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(Gale, Gilbert, Read & Goss, 2014), psychosis (Braehler et al., 2013), bipolar disorder 
(Lowens, 2010), personality disorders (Lucre & Corten, 2013) and non-suicidal self-
injury in young people (van Vliet & Kalnins, 2011). Given there is some overlap 
between borderline personality symptoms and CPTSD symptomology, Lucre and 
Corten’s findings of effectiveness of this approach, as well as its acceptability to 
participants, suggest that compassion-focused interventions may represent a logical 
adjunct to CPTSD treatment. 
 That CFT is clinically indicated for CPTSD populations is supported by a 
qualitative interview study which looked at the process of ‘personally-meaningful’ 
recovery from CSA by Chouliara, Karatzias and Gullone (2014).  Their analysis of 
interviews with 22 adult survivors, male and female, identified four factors important 
to enhancing recovery: ‘new meaningful activity’, ‘formalizing a complaint’, 
‘building inner strength and resources’ (consisting of sub-themes of: ‘ability to feel 
positive emotion’, ‘ recognizing own strengths/good mental health’, ‘self-
compassion’, ‘self as own protector’, ‘standing up for self’)  and ‘disclosing and 
shifting blame’ (with sub-themes of ‘attributing blame to perpetrator’, ‘end of self-
blame’, and ‘weight off shoulders’).  The authors conclude that shame-based and 
compassion-focused interventions are likely to be very helpful for both building inner 
strength and shifting self-blame in PTSD sufferers and should be explored in future 
research.  
Limitations of Research Literature 
The existing research literature provides some support for phase-based 
treatments for CPTSD populations. Given the small number of existing studies 
evaluating phase-based interventions for CPTSD these treatment programmes are still 
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in developmental stages, with insufficient evidence to favour any one type of 
stabilising treatment over another. The interventions in the studies described above 
have largely consisted of psychoeducation about PTSD and emotional regulation 
components. Some, like STAIR-MPE (Cloître et al., 2002) are one-to-one 
interventions but most have a group format. At present no direct comparisons exist of 
outcomes for individual versus group-based stabilisation interventions. There is also 
no consensus regarding the ideal duration of this stabilisation phase. Furthermore, the 
existing studies indicate that attrition rates continue to be an issue for these 
treatments, as for exposure therapies. This suggests that further research is required in 
to order to develop phase-based treatment approaches, including qualitative research 
to generate a better understanding of what treatment approach is best tolerated by this 
clinical population.  
A further difficulty in interpreting the existing research is that there is a lack of 
consensus as to the best way to evaluate treatment outcomes for CPTSD, both in 
terms of how to select research participants, and how to measure CPTSD symptoms, 
in the absence of purpose-designed diagnostic tools or outcomes measures.  Dorrepaal 
and colleagues (2010; 2013) used the SIDES (Pelcovitz et al., 1997) as an outcome 
measure, a lengthy purpose-designed measure for assessing the symptoms of 
DESNOS. Many other authors such as Cloître and colleagues have chosen to use a 
battery of symptom-specific measures, such as measures of anxiety, emotional 
regulation, and interpersonal problems, selecting certain items from them in order to 
tap the complex symptoms of PTSD (e.g. Cloître et al., 2010). With different authors 
using different batteries of measures, drawing comparisons between studies is 
difficult.  
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In terms of research samples, many studies such as Cloître et al. (2002), in the 
absence of agreement about the diagnostic status of CPTSD, have not made a 
diagnosis of CPTSD an inclusion criterion, and have instead selected participants 
based on criteria relating to the nature of their trauma history.  A history of child 
abuse and CSA in particular has often been used as a proxy for diagnosis of CPTSD. 
However, since not all survivors of child abuse have CPTSD symptoms this means 
research studies purporting to study CPTSD may include participants who do not have 
a CPTSD symptom profile. This methodological discrepancy is compounded by a 
lack of clarity in the CPTSD literature about the precipitating traumatic events that 
lead to CPTSD, whether it must be prolonged or repeated trauma or can also be 
caused by a single trauma, and the research literature has not yet established whether 
complex trauma necessarily and specifically results in CPTSD (Resick et al, 2012). 
This makes it problematic to compare outcomes of studies with samples selected 
according to trauma type with studies with samples selected according to CPTSD 
symptoms.   
In addition, existing studies have adopted a range of different exclusion 
criteria, making it more difficult to compare their findings.  A review paper of 34 
outcome studies of PTSD interventions by Spinazzola, Blaustien and van der Kolk 
(2005) found that studies tended to under-report information about exclusion criteria 
and rates, trauma characteristics, and population data. They found that, where 
exclusion criteria are listed, they often encompass quite common comorbidities, such 
as alcohol use issues, as well as other common features such as use of psychotropic 
medication. The authors argue that, as a result, the external validity of many such 
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studies is unproven, and therefore drawing conclusions about treatment for CPTSD 
may be problematic.  
A final shortcoming of the evidence base is that the majority of existing 
CPTSD studies draw on adult populations with historic trauma in childhood. Less is 
known about the effectiveness of phase-based treatments for CPTSD related to adult-
onset trauma, such as torture or intimate partner violence, despite evidence that 
CPTSD also occurs in these populations (Luxenberg et al., 2001). The ISTSS expert 
consensus treatment guidelines note this imbalance and recommend that phase-based 
treatments now be evaluated in populations such as refugees, and others who have 
experienced repeated or prolonged forms of trauma in adulthood (Cloître et al., 2012).  
Since approximately 19 per cent of referrals to the Berkshire Traumatic Stress Service 
consist of adult-onset prolonged traumas such as intimate partner violence, the present 
study aims to contribute to this neglected area of the research literature. 
The Case for CPTSD Research 
The high prevalence of repeated and prolonged trauma in the population 
underlines the importance of research into treatments for people with CPTSD.  
Findings from the US National Comorbidity Study (Kessler, Sonnega, Bromet, 
Hughes & Nelson, 1995) indicated that amongst people who reported having been 
exposed to at least one type of trauma, 64 per cent reported more than one trauma, and 
20 per cent of males and 11 per cent of females reported three or more traumatic 
events.  Therefore, amongst those with PTSD, multiple trauma exposures are more 
common than exposure to a single trauma.  
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Additionally, childhood abuse is increasingly being recognised as a pervasive 
traumatic experience with significant, and often severe, psychological consequences. 
A national survey by the children’s charity NSPCC found that one in four children in 
the UK suffered abuse during childhood (Radford et al., 2011). A large proportion of 
adults seeking help from mental health services report a history of childhood abuse 
(Cloître, Cohen, Han, & Edelman, 2001). Therefore, a treatment designed for those 
with CPTSD, rather than simply PTSD, has the potential for very broad application. A 
US-based study by van der Kolk, Roth, Pelcovitz, Sunday and Spinazzola (2005) 
estimated that nearly half of the treatment-seeking population would meet diagnostic 
criteria for DESNOS. 
Secondly, it is important to note that CPTSD may particularly affect 
populations with cumulative life adversities, such as economically-impoverished 
people of ethnic minorities, homeless people, victims of political repression, 
incarcerated individuals and their families, and those with intellectual or physical 
disabilities, and these cumulative disadvantages may exacerbate the symptoms of 
CPTSD (Vogt, King & King, 2007). Therefore, developing treatment approaches for 
individuals with CPTSD means directing research and resources to some of the most 
disadvantaged members of society (Courtois & Ford, 2009).  
The Present Study 
The above overview of the research literature has shown that, whilst debate 
continues in the academic community about the diagnostic status of CPTSD, a 
growing number of studies are demonstrating the utility of developing treatment 
protocols that go beyond trauma-focused therapy for people with CPTSD symptom 
profiles. The ISTSS expert guidelines have indicated that phase-based treatments are 
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generally seen by experts as a helpful way of stabilising and supporting patients with 
CPTSD symptoms before they undergo the rigours of trauma-focused therapy. The 
methodological variation in the research literature has highlighted the need for 
research that uses CPTSD as an inclusion criterion, and which uses an outcome 
measure which directly assesses the five additional symptom domains of CPTSD 
rather than relying solely on measures of PTSD symptoms.   
The present study is a service-based evaluation of a new, phase-based 
treatment for adults with CPTSD being piloted at the Berkshire Traumatic Stress 
Service (BTSS). The treatment programme was developed in response to the expert 
consensus treatment guidelines for CPTSD published by the ISTSS (Cloître et al., 
2012). The treatment programme consists of three consecutive phases. Phase 1 is a 
six-week psychoeducational group, in which clients are provided with information 
about PTSD and strategies for symptom management. Phase 2 is a twelve-week 
Compassionate Resilience group (CRG) in which clients learn skills of emotional 
regulation, self-soothing and self-compassion, as informed by Paul Gilbert’s 
Compassion-Focused Therapy (Gilbert, 2010).  Phase 3 is the standard treatment for 
PTSD: either trauma-focused CBT or EMDR over the course of 12-16 individual 
sessions, but into which learning from the previous phases is interwoven.  
 This treatment programme is in the piloting stage, and whilst its design is 
closely based on the research literature reviewed above and ISTSS guidelines, its 
effectiveness has not yet been established through empirical evidence. This early-
stage evaluation of the treatment therefore favoured a small-scale, exploratory 
research design. The first two phases in particular - Psychoeducation and CRG - 
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represent a new approach to psychological intervention for CPTSD and therefore 
merit careful evaluation.   
The first aim of this study was to evaluate the effectiveness of the treatment 
programme through a case series analysis of end-to-end outcome data, looking not 
only at PTSD symptoms but also the additional symptom domains of CPTSD and 
levels of self-compassion.  In order to do this, the study also piloted a new, brief 
measure of CPTSD symptoms, the Berkshire Traumatic Stress Service CPTSD 
measure (Billings & Whalley 2015, unpublished), which was designed to be an 
adjunct to the PTSD Checklist (PCL-5) in order to provide a measure of CPTSD 
symptoms, which is lacking in the existing CPTSD outcome research.   
 The second component of the study was to evaluate the acceptability of the 
treatment programme to service users. Evaluating the acceptability of any new 
treatment protocol is vital in ensuring its long-term viability, and is perhaps 
particularly important for this treatment programme in the light of various distinctive 
features: the division of the treatment into three separate components with gaps in-
between, the group-based format of the first and second phases, and the lengthy (30 
weeks minimum) commitment demanded of clients. Furthermore, the views of service 
users are increasingly seen as a necessary component in service evaluation, and since 
the Health and Social Care Act 2008, all health and social care bodies are obliged to 
publicly set out how they will ensure they listen to the views of service users and 
carers (Health and Social Care Act, 2008), with service user and carer involvement 
now assessed as part of standard CQC monitoring of services.   
This naturalistic, service-based study sought to make use of pre-existing 
service structures for outcome data collection in order to minimise the burden on 
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participants.  Due to an administrative difficulty at the service with updating of 
measures, at the point of analysis none of the service users who had completed correct 
measures at assessment had yet completed the third phase of treatment. They 
therefore met inclusion criteria for the case series analysis but not for the end-of-
treatment interview.  As a result, whilst the original intention was to use the same 
sample of participants for both components of the study, instead the second 
component of the study recruited a separate sample of participants who had completed 
the whole treatment (but not the up-to-date outcome measures), and who were 
therefore able to provide important qualitative data about all three phases. 
The research questions for the present study were as follows: firstly, how 
effective is this phase-based approach for treating the symptoms of both PTSD and 
the five additional symptom domains of CPTSD?  Secondly, what symptoms change 
following each phase of the treatment? It was predicted that no change or only small 
spontaneous changes in PTSD and CPTSD symptoms would occur over Phase 1, 
Psychoeducation, which is designed to educate rather than to treat symptoms.  It was 
predicted that differential change would be evident over Phase 2, CRG, with a greater 
rate of reduction in CPTSD symptoms than in PTSD symptoms, and improvements in 
self-compassion. In the third phase, consisting of trauma-focused therapy, it was 
predicted that there would be a greater rate of reduction in PTSD symptoms than in 
CPTSD symptoms. The third and final research question probed the acceptability of 
the treatment to service users, and explored participants’ views and experiences of the 
treatment.  
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Chapter 2: Methods 
Participants 
The study consists of two components: the first, a case series analysis of 
outcome data assessing the effectiveness of the treatment; and the second, a 
qualitative analysis of interviews with clients regarding its acceptability. The sample 
for the first component was nine, all of whom were women. This reflected the higher 
rate of female referrals for CPTSD, in combination with the fact that some male 
service users were waiting for an all-male CRG group to start. The sample for the 
second component of the study was six, consisting of one man and five women.   
All participants were recruited from the Berkshire Traumatic Stress Service 
(BTSS), a national specialist NHS centre for the treatment of adults with PTSD. The 
service is pioneering this three-phase treatment protocol for CPTSD.  
Inclusion criteria for both components of the study were as follows: over 18 
years of age; accepted for treatment at the Berkshire Traumatic Stress Service; meets 
diagnostic criteria for PTSD with additional CPTSD features; able to complete 
questionnaires in English; able to understand and participate in an interview 
conducted in English (second component only). PTSD diagnosis was assessed in 
accordance with PTSD diagnostic criteria for DSM-V, and CPTSD features assessed 
in accordance with the ISTSS expert consensus guidelines regarding CPTSD (Cloître 
et al., 2012). All clinician decisions regarding diagnosis and suitability for treatment 
were mutually agreed at service team meetings.  
There were no exclusion criteria for participation in the study. However, the 
BTSS has exclusion criteria at screening stage. These are: extreme emotional 
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instability, acute suicidality or a high level of substance dependence, such that the 
client would not be stable enough to tolerate treatment. 
For the first component of the study, clients who had completed at least the 
first two phases of treatment as well as regular outcome measures were invited to 
participate. Of the nine who were invited to participate, all consented to participate.  
For the second component of the study, clients who had recently completed all 
three phases of the treatment, and had agreed to be contacted for research purposes, 
were invited to be interviewed. Of the six who were invited, all consented to 
participate. 
No incentives were offered for participation; however, participants who 
travelled in order to participate were reimbursed up to £10 of expenses.  
Attrition 
 Figure 1 indicates how the final case series sample of nine was arrived at, 
from an original 127 people assessed as having CPTSD at BTSS in 2015.  Fifty-one 
of the 127 did not enrol in the full, three-phase treatment programme, of whom 15 
either chose not to do a group treatment, or their clinician judged them unsuitable for 
a group. Of the 76 who did enrol in the full treatment programme, 16 were discharged 
before starting treatment. Reasons for discharge included spontaneous recovery, 
changes in circumstances or no longer wishing to begin therapy.  A further five 
people were discharged after Phase 1, again either due to remission, or due to 
choosing not to continue.  Six people were not eligible for inclusion because they did 
not do the CRG group, although they stayed in some form of treatment. Thirty-nine 
people could not be included in the case series analysis because they had not yet 
completed two phases. 
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Figure 1: Attrition from Case Series from Point of Assessment 
 
Ethics 
Ethical approval for the study was granted by the Proportionate Review Sub-
Committee of the National Research Ethics Service North West – Preston Research 
Ethics Committee, and the Royal Holloway Departmental Ethics Committee. 
Recruitment was approved locally by Berkshire Healthcare NHS Foundation Trust 
Research and Development department. See Appendices A-D for approval letters.  
In consenting to participate, all participants gave permission for the researcher 
to access their clinical notes at BTSS in order to obtain participant biographical and 
trauma details, as well as information about any intervening events that may have 
impacted on their engagement with treatment or their symptom scores. 
41 
 
Design  
There were two components to this study. This first consisted of a case series 
analysis of participant outcome data from measures of PTSD and CPTSD, anxiety, 
depression, self-compassion and general functioning, all obtained at regular intervals 
throughout the phase-based treatment. This component sought to answer the first and 
second research questions pertaining to the effectiveness of the treatment programme 
and the degree of symptom change observable in each of the phases of the phase-
based treatment. The second component of this study consisted of a qualitative 
analysis of semi-structured interviews with participants who had reached the end of 
their treatment. This component was designed to respond to the third research 
question pertaining to the acceptability of the treatment programme to patients. A 
qualitative, semi-structured interview approach was preferred over a questionnaire 
approach in order to allow the emergence of a broad range of themes relating to 
treatment acceptability. 
Measures 
All participants for the first (case series) component of the study completed 
the following self-report measures:  
PTSD Checklist for DSM-5 (PCL-5; Weathers, Litz, Keane, Palmieri, 
Marx, & Schnurr, 2013). See Appendix E.  The PCL-5 is a widely-used 20-item 
self-report measure that assesses the DSM-5 symptoms of PTSD. Each item is rated 
0-4, with a maximum total score of 80. It is a self-report measure that can be 
interpreted to provide a provisional diagnosis, overall severity score and severity 
scores linked to DSM-5 diagnostic clusters.  
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 The PCL-5 is an updated version of the PCL for DSM-IV reflecting the 
revised diagnostic criteria. As a recent revision, psychometric information is not yet 
available for the PCL-5; however, studies of the psychometric properties of the 
previous version, the PCL-S for DSM-IV, indicate good reliability and validity. In a 
sample of 40 road traffic accident and sexual assault victims, Blanchard, Jones-
Alexander, Buckley, and Forneris (1996) found an alpha of .94 and an overall 
correlation between total PCL-S score and CAPS scores of .93. In a study of people 
who had experienced a variety of traumas, Ventureya, Yao, Cottraux, Note, and 
Guillard (2002) reported excellent internal consistency (.86) and test-retest reliability 
(.80) for the total PCL-S score. 
Berkshire Traumatic Stress Service CPTSD measure (BTSS CPTSD; 
Billings & Whalley 2015, unpublished). See Appendix F. This additional, brief, 
purpose-designed measure consists of four self-report items appended to the PCL-5 in 
order to probe for the four complex PTSD symptom dimensions (difficulties 
regulating emotions; difficulties in interpersonal relationships; dissociation; 
somatisation) described by ISTSS guidelines (Cloître et al, 2011) and not already 
probed by the PCL-5. The fifth CPTSD symptom area (alterations in beliefs) is 
included in the PCL-5. The response options are the same as those for the PCL-5 (Not 
at all / A little bit / Moderately / Quite a bit / Extremely), with each item rated 0-4. As 
with the PCL-5, participants are asked to rate their symptoms in the past month.  
Forms of Criticism and Self-Reassurance Scale (FCSRS; Gilbert, Clarke, 
Hempel, Miles, and Irons, 2004).  See Appendix G. The FCSRS is a 22-item 
measure that developed from Gilbert’s clinical work concerning self-criticism and the 
ability to self-reassure. The scale is made up of three factors: Inadequate Self (a sense 
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of feeling internally put down and inadequately following failure), Hated Self (a sense 
of self-dislike and aggressive/persecutory desires to hurt the self following failure), 
and Reassured Self (a sense of encouragement and concern for self when things go 
wrong). Cronbach’s alphas of over .86 for each subscale are reported by the authors.  
A study consisting of a clinical sample of 304 people with Axis I and II 
diagnoses and a nonclinical sample of 381 examined the psychometric qualities of the 
FCSRS. It found good discriminant validity between Inadequate Self and Reassured 
Self and between Inadequate Self and Hated Self in the clinical sample. Discriminant 
validity was less evident between Hated Self and Reassured Self (Castilho, Pinto‐
Gouveia & Duarte, 2015).  In the same study test-retest reliability was good for the 
subscales Inadequate Self (r=0.72), Hated Self (r=0.78) and Reassured Self (r=0.65). 
Convergent validity was assessed between FCSRS and self-report measures that 
evaluate theoretically-related constructs (the Depression Anxiety and Stress Scales, 
General Health Questionnaire, Levels of Self-Criticism Scale, Self-Compassion Scale, 
and Life Orientation Questionnaire Test-Revised). Overall, the pattern of correlations 
found suggested that FCSRS and its subscales have good convergent validity. 
Additionally, the ability of the FCSRS to discriminate between clinical and non-
clinical populations was assessed and revealed significant differences between the 
clinical and nonclinical samples on all subscales.  
 Patient Health Questionnaire-9 (PHQ-9; Kroenke & Spitzer, 2002). The 
PHQ-9 is a nine-item questionnaire based on DSM-IV diagnostic criteria for 
depression, which is widely used in primary care settings. Respondents are asked to 
rate how they have felt in the last two weeks; each item is scored 0-3 with a maximum 
total score of 27. It can be used to screen for depression as well as to grade depressive 
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symptom severity. Two large-scale validation studies have established good criterion 
and construct validity of the PHQ-9 as both a diagnostic and severity measure 
(Kroenke & Spitzer, 2002). It has also been shown to be a sensitive measure of 
change in depression over time, indicating its validity as an outcome measure to 
evaluate treatment response (Löwe, Kroenke, Herzog & Gräfe, 2004). 
Generalised Anxiety Disorder scale-7 (GAD-7; Spitzer, Kroenke, 
Williams, Löwe, 2006). The GAD-7 is a seven-item self-report measure of anxiety 
that is widely used in primary care settings. Again, respondents are asked to rate how 
they have felt in the last two weeks; each item is scored 0-3 with a maximum total 
score of 21.  It has been demonstrated to have good reliability, as well as criterion, 
construct, factorial, and procedural validity and therefore performs well as a screening 
tool for generalised anxiety disorder and for assessing the severity of anxiety 
symptoms (Spitzer et at., 2006).  
Work and Social Adjustment Scale (WSAS; Mundt, Marks, Shear & 
Greist, 2002). The WSAS is a brief 5-item scale that measures functional impairment 
attributable to an identified problem or disorder across the domains of home, work, 
social leisure, private leisure, and relationships.  Each item is rated 0-8 according to 
the extent to which the problem prevents them from carrying out activities in each 
domain, with a maximum total score of 40. It is used clinically as an outcome 
measure with depression, anxiety and alcohol misuse populations. There have so far 
been no studies measuring its validity in measuring impairment in PTSD or Complex 
PTSD populations, however for depression and anxiety disorders it has good 
convergent validity with clinically-assessed disorder severity, as well as with clients’ 
global impressions of perceived improvement (Mundt et al., 2002). 
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Semi-structured post-treatment interview. For the second component of the 
study participants were interviewed individually using a semi-structured interview 
protocol (see Appendix H). This was designed to probe their experience of the 
treatment overall and of each individual phase. 
The interview schedule evolved over the first few interviews to incorporate 
feedback and suggestions from participants. Participants were asked to comment on 
the content of the interview schedule as well as the process and experience of the 
interview.  
Procedure 
 Participants were invited to participate in the study by their assessing clinician 
at BTSS, given a participant information sheet (Appendix I), and informed that their 
decision would not affect their treatment at BTSS in any way.  Those who agreed 
were then asked to sign a consent form (Appendix J) no less than 24 hours later. 
Participants were informed of their right to withdraw at any time, and of how their 
confidentiality would be ensured.  
For the case series component of the study, participants were asked to 
complete self-report measures at multiple points throughout treatment. Table 1 shows 
the time points at which measures were administered. These time points were chosen 
to be roughly evenly spaced throughout the treatment programme. Whilst maximising 
the number of data points is preferred in a case series analysis in order to gain an 
accurate picture of symptom change over time, the number of time points in the 
current study was limited by a need to mitigate participant burden, particularly since 
several standardised measures were administered at each data point. 
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Table 1: Data Collection Time Points and Measures  
Time point Treatment stage Measures 
1 Assessment at BTSS Self-report measures 
2 Pre-Psychoeducation Self-report measures 
3 Post-Psychoeducation Self-report measures 
4 Pre-CRG Self-report measures 
5 Mid-CRG Self-report measures 
6 Post-CRG Self-report measures 
7 Pre-Individual treatment Self-report measures 
8 Mid-Individual treatment Self-report measures 
9 Post-Individual treatment Self-report measures  
10 Follow-up (min. 1 week) Self-report measures & Interviews 
 
For the interview component of the study, interviews were conducted by the 
researcher either in person (n=5) or by telephone (n=1), according to participant 
preference. Participants were made aware that the researcher was independent of 
BTSS, and that their responses would be confidential and not shared with clinicians. 
Interviews were between 18 and 44 minutes in duration (mean = 32 min) and were 
audio recorded and then transcribed. Participant personal and trauma details were 
disguised in the presentation of findings in order to protect confidentiality.  
Case series analysis.  The graphical analysis of case series data was 
conducted according to guidance offered by Morley and Adams (1991) for clear 
graphical presentation of single case data in clinical psychology research. The 
approach to the analysis was informed by the data, in particular the small number of 
data points per phase, due to the use of standardised rather than idiographic measures.  
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The trend line fitted to all data was the running median of 2, which is 
considered most appropriate for ‘n < 5’ case series designs where ‘n’ is the number of 
data points per phase (Morley, in prep.). The measure of central tendency selected 
was the phase median, again dictated by the small number of data points and as 
recommended by Morley. Measures of variability within each phase were judged to 
be unhelpful due to the low number of data points, and likely to complicate the visual 
analysis, where clarity is highly important (Morley & Adams, 1991).  
Relying on visual, graphical analysis of case series data without the addition 
of statistical analyses is considered acceptable by many case series researchers, and 
Morley argues that the decision of whether or not to add statistical analysis should be 
based on the nature of the data being analysed (Morley, 1994). Whilst some case 
series researchers advocate the use of statistical analysis in order to establish 
statistically-significant differences between phases, usually through the use of non-
overlap statistics (e.g., Kazdin, 2007; Shadish, 2014), the small number of data points 
per phase in the present study design was judged to render such analyses 
inappropriate. 
Thematic analysis. Transcripts were analysed thematically. Thematic analysis 
is a method of searching across a data set and identifying, analysing and reporting 
themes within the data. The thematic analysis of the interview transcripts enabled 
identification of emergent themes regarding clients’ experiences of the treatment.  The 
interview transcripts were coded using the software package Atlas.Ti.6 
(Cleverbridge). 
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Treatment Content  
Figure 2 shows the structure of the three-phase treatment programme. The 
length of time between treatment phases varied according to the individual’s pathway 
through treatment.   
 
Figure 2: BTSS Treatment Schedule Indicating Duration of Treatment Phases 
Table 2 provides a summary of the content of the three treatment phases. 
Psychoeducation is a group intervention lasting 6 weeks, with each weekly session 
lasting 75 minutes. Groups are mixed or single sex according to client preference, 
with a maximum of ten members.  Clients are given a workbook containing teaching 
materials and between-session tasks, as well as a booklet called ‘Understanding and 
coping with PTSD’.  
Compassionate Resilience group (CRG) is a group intervention lasting 12 
weeks, with each session lasting 2 hours. Groups are single-sex and have up to 8 
members. There is a one-off pre-group meeting for group members to meet each other 
and be informed about the nature of the group. Again, clients are given a workbook 
containing teaching materials and between-session exercises. Skills development, 
such as soothing rhythm breathing and mindful attention, run throughout the 12 
weeks.  
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Phase three consists of a one-to-one trauma-focused therapy in one of two 
evidence-based models: trauma-focused Cognitive Behavioural Therapy (CBT), or 
Eye Movement Desensitisation and Reprocessing (EMDR), the decision being made 
collaboratively between client and clinician. 
Table 2: Treatment Content by Phase 
Content of phases by session 
Phase 1: Psychoeducation 
group 
Phase 2: Compassionate 
Resilience group (CRG) 
Phase 3: Individual 
therapy 
1: PTSD symptoms & 
formulation 
2: Threat system & 
physiology. Relaxation 
techniques. 
3: Nature of traumatic 
memories. Grounding 
techniques. 
4: Beliefs in trauma. Safe 
place exercise. 
5: Avoidance. Values-based 
behavioural activation. 
6: Recap and discuss 
treatment. 
1-4: Psychoeducation about 
the compassion model: what 
is threat? What is 
compassion?  
5-8:  Exploring fears and 
blocks to developing 
compassion; shame and self-
criticism.  
9-12: Compassionate 
problem-solving and 
compassionate coaching. 
‘You at your best’ and ‘The 
perfect nurturer’ exercises. 
12-16 sessions of 
trauma-focused 
Cognitive Behavioural 
Therapy, or Eye 
Movement 
Desensitisation and 
Reprocessing 
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Chapter 3: Results of Case Series 
Two separate analyses were carried out: a case series analysis and a thematic 
analysis; findings of the case series analysis are presented first.  
Table 3 shows the main characteristics of the sample for the case series 
analysis.  Table 4 provides a clinical summary of case series participants according to 
standardised measures of PTSD, depression, general anxiety and functioning at pre- 
and post-treatment, with clinically-significant change indicated by bold text. Since all 
case series participants were still in treatment at the time of analysis, the table 
indicates the latest data point available for each participant, which was used for 
pre/post analyses.  
Table 3: Case Series Participant Characteristics 
ID Sex Age Trauma type 
1 F 30 Child sexual and physical abuse 
2 F 20 Child sexual abuse and exposure to violence 
3 F 45 Childhood exposure to violence, and traumatic childbirth 
4 F 38 Adult intimate partner violence 
5 F 47 Child sexual and physical abuse, and adult intimate partner 
violence 
6 F 44 Child sexual and physical abuse and adult intimate partner 
violence  
7 F 48 Adult intimate partner violence 
8 F 23 Adult intimate partner violence 
9 F 43 Child sexual abuse  
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Table 4: Clinical Summary of Case Series Participants 
ID Latest available 
data point 
PCL-5 GAD-7 PHQ-9 WSAS 
P
re
 
P
o
st
a  P
re
 
P
o
st
a  P
re
 
P
o
st
a  P
re
 
P
o
st
a  
1 Mid-individual 59 32 20 7 21 14 27 20 
2 Mid-individual 69 25 16 5 20 2 20 4 
3 Mid-individual 57 24 21 11 22 10 24 17 
4 Mid-individual 48 43 12 17 11 11 4 6 
5 Pre-individual 36 37 7 6 11 13 14 20 
6 Pre-individual 62 63 17 18 21 26 31 34 
7 Post-CRG 62 16 16 1 14 1 30 8 
8 Post-CRG 66 40 19 8 20 14 16 13 
9 Post-CRG 51 37 9 13 15 17 19 22 
a
 'Post' indicates latest available data.  
Note. Bold text indicates clinically significant change calculated using Jacobson’s 
Reliable Change Index (no clinical cut off for WSAS) 
 
Pre-Post Changes in PTSD Symptomology 
Figure 3 shows change on PCL-5 total score for all participants in the case 
series, comparing scores at assessment with scores at the post-CRG point, and 
indicating those participants who showed reliable and clinically-significant change. 
Post-CRG was used as a post-treatment data point for consistency, since that stage of 
treatment had been achieved by the whole sample, and also because it represents the 
change in scores after completion of Phases 1 and 2 of the treatment programme. The 
clinical cut-off score of 44 was based on recommendations of Blanchard et al.’s 
(1996) study of motor accident and sexual assault survivors. Reliable change was 
calculated according to Jacobson’s Reliable Change Index. The figure indicates that 
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three of the nine participants showed clinically-significant improvement on the PCL-5 
at the post-CRG point.  
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Figure 3: Reliable and Clinical Change for PCL-5 at Post-CRG 
Figure 4 shows change on PCL-5 total score from assessment to the latest 
available data point (indicated in Table 4). For four participants the latest available 
data was at mid-individual treatment, for two participants it was at pre-individual 
treatment, and for three participants it was at post-CRG.  Therefore, for six of the nine 
case series participants Figure 4 shows post-treatment data from a later stage in 
treatment than Figure 3.  
Figure 4 shows that at the latest available data point, five of the nine 
participants showed reliable and clinically-significant improvement on the PCL-5. 
Comparison of Figure 3 with Figure 4 suggested that overall degree of improvement 
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in PTSD symptoms, as measured by the PCL-5, was partly a function of participants’ 
stage of progress through the treatment programme.   
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Figure 4: Reliable and Clinical Change for PCL-5 at Latest Available Data Point 
 
Results for each participant of the case series analysis are presented 
sequentially. Participant background information, obtained from their clinical notes 
with consent, has been disguised to protect confidentiality. Data points after wait 
periods are indicated by hollow markers. 
Participant 1 
P1 was a thirty-year old woman of White-British origin who experienced 
repeated emotional, physical and sexual abuse by several adults known to her between 
the ages of 5 and 16.  Her PTSD symptoms started in childhood but were made worse 
when one of the perpetrators was released from prison shortly before the assessment.  
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She described suffering frequent nightmares and flashbacks as well as hyperarousal, 
panic, poor sleep, and dissociative ‘zoning out’. In addition, she described difficulties 
trusting others and feeling cut off, as well as high levels of self-criticism and shame. 
She suffered from low mood and was taking an SSRI at the time of assessment. She 
had attempted suicide in the past and reported recent suicidal ideation but no current 
intent to harm herself.  She also suffered from an unexplained health problem. 
P1 did not attend two of the six Psychoeducation sessions and four of the 12 
CRG sessions due to ill-health and practical difficulties.  At the time of analysis P1 
had completed eight sessions of trauma-focused individual treatment (of 12-16 
sessions offered).  
Generic measures. P1’s scores on measures of depression, anxiety and 
functioning (PHQ-9, GAD-7 and WSAS) are shown in Table 5. As P1 had not 
finished individual treatment, no scores were available for time points 9-10.  The data 
indicated that from assessment to mid-individual treatment P1’s scores for both the 
PHQ-9 and GAD-7 improved to a reliable degree. On the WSAS, which is not a 
diagnostic tool but assesses broader functioning, P1 showed no overall change in 
score from assessment to mid-individual treatment. Scores in-between indicate some 
deterioration in functioning during Psychoeducation, returning to the original level 
over the course of the CRG.   
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Table 5: P1 PHQ-9, GAD-7 and WSAS scores 
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M
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d
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. 
PHQ
-9 
21 17 22 25 23 11 13 14 -7 Y N Severe to 
moderate 
GAD
-7 
20 14 15 20 20 6 6 7 -13 Y Improve Severe to 
<clinical 
WSA
S 
27 28 38 38 37 26 27 20 -7 N n/a n/a 
a 
Reliable Change and Clinically-Significant Change calculated using Jacobson’s Reliable 
Change Index 
Graphical analysis. Results for the PCL-5, Complex PTSD items and FCSRS 
sub-scale scores are presented graphically in Figures 5, 6 and 7 respectively.  
Figure 5 indicates that P1’s PCL-5 total score, which was 59 at assessment, 
decreased overall from assessment to mid-treatment (32). Visual analysis of the graph 
indicates a slight upward trend in symptom severity during Phase 1 followed by a 
downwards trend in severity during Phase 2.   This suggests that the Psychoeducation 
group had a negative effect on PTSD symptoms but the CRG had a positive effect. 
Deterioration is visible after the wait between Phase 1 and 2 (time point 4), however 
by contrast, symptom improvement during the CRG continued in the wait period after 
(time point 7). The limited data available for Phase 3 showed continued improvement 
in PTSD symptoms over the first half of individual treatment.  
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Figure 5: P1 PCL-5 Total Score 
 
Figure 6 shows P1’s scores on the five ‘Complex’ symptom domains of 
CPTSD, assessed by all four items of the BTSS CPTSD measure (measuring 
Emotional, Interpersonal, Dissociative and Somatic symptoms), in addition to Item 9 
from the PCL-5 probing negative beliefs about self, others or the world.   Visual 
analysis revealed that trends for the five CPTSD symptom items were similar, 
showing no change or a slight upward trend during Phase 1, followed by a downwards 
trend in Phase 2. Similar to the trend in PCL-5 total score, this suggests that 
Psychoeducation was not helpful for alleviating CPTSD symptoms, whereas CRG 
was helpful.  In all cases the improvement during the CRG was sustained in the 
waiting period after (time point 7).  Missing data in Phase 1 made it impossible to 
draw conclusions about symptom change in the wait period after the Psychoeducation 
group (time point 4).  Data for Phase 3 up to the first half of individual treatment 
indicated that most CPTSD symptom areas continued to improve, although the 
Somatic item showed deterioration.  
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Figure 6: P1 Complex PTSD Symptoms (BTSS CPTSD items & PCL-5 Item 9) 
 
Figure 7 shows P1’s scores on the three subscales of the FCSRS. According to 
visual analysis of the data, the trend on all three subscales of the measure was for no 
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change or slight deterioration during Phase 1, followed by marked improvement 
during Phase 2 (decreases in Hated and Inadequate Self, increase in Reassured Self). 
This suggests that Psychoeducation had little effect, or a negative effect, on self-
compassion ratings, whereas the CRG may have been helpful. Gains appear to have 
continued during the waiting period after the CRG for Hated and Inadequate Self, but 
not for Reassured Self. In Phase 3, the data suggested some improvement for 
Inadequate and Reassured Self in the first half of individual treatment, but no change 
for Hated Self.  
0
1 0
2 0
3 0
4 0
H a te d  s e l f
0
1 0
2 0
3 0
4 0
In a d e q u a te  s e l f
1 2 3 4 5 6 7 8 9 1 0
0
1 0
2 0
3 0
4 0
T im e  p o in t
F
C
S
R
S
R e a s s u r e d  s e l f
P h a s e  m e d ia n
T re n d
 
Figure 7: P1 FCSRS Subscales: Hated Self, Inadequate Self, Reassured Self 
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Overall it appeared that, for P1, Psychoeducation did not have any impact on 
the generic measures of anxiety, depression and function, nor on PTSD, CPTSD 
symptoms and self-compassion.  However, it is important to note that the participant 
was not able to attend one third of the sessions that were offered in Psychoeducation.  
By contrast, the CRG appears to have been helpful for P1 in terms of PTSD, CPTSD 
and self-compassion, and gains during the CRG were generally sustained in the wait 
period after. Improvement on all measures appeared to continue in the first part of 
Phase 3. 
Participant 2  
P2 was a 20-year-old woman of Irish descent who experienced CSA 
perpetrated by two cousins and her uncle from the age of 6 to 13. She had not felt able 
to report the abuse. As a child she also repeatedly witnessed her mother suffer 
domestic violence perpetrated by her father. At assessment P2 reported distressing 
visual and olfactory flashbacks on a weekly basis, and nightmares. She struggled with 
sexual intimacy due to it triggering flashbacks. She had periods of depression and had 
recent episodes of self-harm, though no suicidal ideation.  She held strong negative 
beliefs about herself which had led to some self-neglect, and she struggled with 
relationships, experiencing others as rejecting. She also had difficulty managing her 
anger at times. Prior to assessment at BTSS P2 had had previous mental health 
services contact and an intervention designed to address features of Borderline 
Personality Disorder. She was not taking any medication.  
P2 attended all sessions of Psychoeducation and the CRG. At the time of 
analysis she was engaging well with individual treatment and had attended eight 
sessions.  
60 
 
Generic measures. P2’s scores on depression, anxiety and functioning 
measures (PHQ-9, GAD-7 and WSAS) are shown in Table 6. As P2 had not reached 
the post-individual treatment point, no scores were available for time points 9 or 10.  
The data indicates that from assessment to mid-individual treatment P2’s scores 
reduced from being in the severe range for both the PHQ-9 and GAD-7, to being 
below accepted clinical cut-off scores for both (IAPT, 2011).  On the WSAS P2 
showed marked improvement. 
Table 6: P2 PHQ-9, GAD-7 and WSAS scores 
 
 
 
 
 
 
1 2 3 4 5 6 7 8 
P
re
/P
o
st
 
R
C
a  
C
S
C
a  
In
te
rp
re
ta
ti
o
n
 
A
ss
es
s.
 
P
re
-P
sy
ch
. 
P
o
st
-P
sy
ch
. 
P
re
-C
R
G
. 
M
id
-C
R
G
. 
P
o
st
-C
R
G
. 
 P
re
-I
n
d
iv
. 
M
id
-I
n
d
iv
. 
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16 17 12 14 2 3 4 5 -11 Y Improve Severe to 
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WSAS 20 17 24 10 4 4 6 4 -16 Y n/a n/a 
 a
 Reliable Change and Clinically-Significant Change calculated using Jacobson’s 
Reliable Change Index 
Graphical analysis. Results for the PCL-5, Complex PTSD items and FCSRS 
sub-scales are presented graphically in Figures 8, 9 and 10 respectively.  
Figure 8 indicates that P2’s PCL-5 total score reduced considerably from 
assessment (69) to mid-treatment (25).  Visual analysis of the graph suggests that, of 
the two phases for which complete data was available, both appear to have had a 
positive effect on PTSD symptoms, with the CRG group having the greatest impact. It 
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was not possible to draw conclusions about Phase 3 from the data points available, 
though the trend in PCL-5 score for the first half of individual treatment appears to be 
a continued downward one.  Deterioration in symptoms is visible after the wait 
between Phase 1 and 2 (time point 4) and the wait between Phase 2 and 3 (time point 
7). 
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Figure 8: P2 PCL-5 Total Score 
Figure 9 shows P2’s scores on the five ‘Complex’ symptom domains of 
CPTSD. The trends on the five graphs are similar, and show a marked difference 
between the central tendency for Phase 1 and Phase 2. The trend lines indicated 
reductions in symptoms across both Phase 1 and Phase 2, as well as deterioration in 
the wait periods between these phases. The ‘Beliefs’ domain differed to the other 
domains by showing no reduction in symptom frequency in Phase 1, but, like the 
others, showed reductions over Phase 2.  Overall, visual analysis of these graphs 
suggests that Psychoeducation was helpful in reducing most CPTSD symptoms, and 
CRG was helpful for all CPTSD symptoms. The limited data for Phase 3 suggests 
either continued improvement or at least maintenance of gains over the first half of 
individual treatment.   
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Figure 9: P2 Complex PTSD Symptoms (BTSS CPTSD items & PCL-5 Item 9) 
 
Figure 10 shows P2’s scores on the three subscales of the FCSRS. The trend 
on all three subscales was for improvement (reductions in Hated Self and Inadequate 
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Self; an increase in Reassured Self) in Phases 1 and 2, according to visual analysis of 
the data. For Hated Self the trend appears similar across Phase 1 and 2, suggesting 
they were equally helpful. Inadequate Self, which was rated very highly at 
assessment, showed the steepest improvements in Phase 2. Reassured Self also 
showed the steepest improvement in Phase 2. This suggests that although both 
Psychoeducation and CRG appear to show improvements on the FCSRS, the CRG 
was the most effective phase of treatment for P2 in reducing self-criticism and 
increasing the capacity to self-reassure. The limited data available for Phase 3 
indicates little change on any of the FCSRS subscales in the first half of individual 
treatment.  
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Figure 10: P2 FCSRS Subscales: Hated Self, Inadequate Self, Reassured Self 
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Overall, for P2, it appeared that both Psychoeducation and CRG may have 
been instrumental in improving PTSD and some CPTSD symptoms. With only two 
data points for Phase 3 it was difficult to draw conclusions about the impact of 
individual treatment on scores; however the trend appeared to show that 
improvements on the PCL-5 continued in the first half of individual treatment 
whereas improvements on CPTSD items and FCSRS slowed down. This reflected the 
explicit emphasis of Phase 3 on reducing PTSD symptoms, rather than targeting 
CPTSD symptoms or self-compassion.  
Participant 3 
P3 was a 45-year-old woman of White British background who suffered 
emotional abuse from her father as a child, and witnessed domestic violence towards 
her mother. As an adult she experienced a traumatic childbirth. She had a number of 
PTSD symptoms at assessment including flashbacks, intrusive memories, difficulty 
sleeping, dissociation, poor concentration and medically-unexplained pain. It was not 
clear which symptoms were related to which trauma. She described strong feelings of 
shame and embarrassment, and negative beliefs about herself such as ‘I deserve to be 
punished’.  She held beliefs about the dangerousness of the world, described feeling 
cut off from others and was low in mood. Prior to treatment at BTSS P3 had been 
admitted to hospital for an acute stress reaction triggered by family difficulties. She 
was taking beta blockers, sleeping tablets and an SSRI.  
65 
 
P3 attended all Psychoeducation sessions. She was unable to attend three of 
the CRG sessions due to a bereavement. At the time of analysis P3 had attended seven 
sessions of individual therapy.   
Generic measures. P3’s scores on measures of depression, anxiety and 
functioning are shown in Table 7. As P3 had not reached the end of individual 
treatment, no scores were available for time points 9-10.  The data indicates that from 
assessment to mid-individual treatment P3’s scores reduced from being in the severe 
range to being in the moderate range for both depression and anxiety (IAPT, 2011), 
although the improvements did not meet criteria for CSC.  On the WSAS there was no 
assessment score due to missing data, and no reliable change overall. 
Table 7: P3 PHQ-9, GAD-7 and WSAS scores 
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22 24 21 15 27 9 12 10 -12 Improve N Severe to 
moderate 
GAD
-7 
21 21 21 20 21 11 13 11 -10 Improve N Severe to 
moderate 
WSA
S 
- 24 28 26 23 19 18 17 -7 N n/a n/a 
a 
Reliable Change and Clinically-Significant Change calculated using Jacobson’s Reliable 
Change Index 
Graphical analysis. Results for the PCL-5, Complex PTSD items and FCSRS 
sub-scale scores are presented graphically in Figures 11, 12 and 13 respectively.  
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Figure 11 illustrates that P3’s PCL-5 total score improved reliably overall 
from assessment (57) to mid-individual treatment (24).  Visual analysis of the trend 
line indicated that P3’s PCL-5 score increased over Phase 1 and decreased over Phase 
2, suggesting that Psychoeducation increase symptoms whereas the CRG reduced 
symptoms. The gains in Phase 2 were partly lost in the wait period after (time point 
7).  The available data for Phase 3 indicated that PTSD scores reduced markedly over 
the first half of individual treatment.  
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Figure 11: P3 PCL-5 Total Score 
Figure 12 shows P3’s scores on the five ‘Complex’ symptom domains of 
CPTSD. The lines of central tendency for most items indicate very little change 
between Phase 1 and Phase 2. However, this statistic obscures changes that did occur. 
The trend lines indicate that all CPTSD items except Beliefs showed some slight 
improvement during Psychoeducation (time point 3) although gains were lost in the 
waiting period after. Additionally, all symptoms showed improvements during the 
CRG, particularly the second half (time point 6), although, again, for several 
symptoms gains were partly lost in the waiting period after.  
Overall, visual analysis of P3’S CPTSD scores indicated that Psychoeducation 
may have been somewhat helpful in alleviating symptoms but gains were not 
67 
 
sustained, whereas the CRG appeared to show a sustained positive impact on all 
CPTSD symptoms except Somatic.  For Phase 3, data for the first half of individual 
treatment showed improvements on all five items, suggesting that individual 
treatment may have had a positive impact on CPTSD symptoms.   
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Figure 12: P3 Complex PTSD Symptoms (BTSS CPTSD items & PCL-5 Item 9) 
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Figure 13 shows P3’s scores on the three subscales of the FCSRS. Visual 
analysis indicated deterioration in self-compassion (increase in Hated and Inadequate 
Self; decrease in Reassured Self) on all FCSRS dimensions across Phase 1.  In Phase 
2 there was a trend of reduction in scores for Hated and Inadequate Self, and no 
change for Reassured Self. This suggests that Psychoeducation was not helpful but 
CRG did have a moderate effect in reducing self-criticism, although it did not appear 
to impact on P3’s capacity for self-reassurance. For Phase 3, the available data 
showed some improvement on Inadequate Self and Reassured Self but an increase in 
score for Hated Self.  
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Figure 13: P3 FCSRS Subscales: Hated Self, Inadequate Self, Reassured Self 
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Overall for P3, Psychoeducation appeared to have had a negative effect on 
PTSD, CPTSD symptoms and FCSRS ratings, whereas CRG appear to show positive 
effects on all these measures, despite a bereavement and several missed sessions, and 
these gains were generally partly sustained in the wait period after the CRG.  
Individual treatment, based on data for the first half only, appeared to be associated 
with a reduction in both PTSD and CPTSD symptoms.  
Participant 4 
P4 was a 38-year-old mixed-race woman who experienced a sexually abusive 
and controlling relationship culminating in a serious physical assault two years prior 
to assessment at BTSS. Although the relationship ended, there was ongoing threat 
from her ex-partner, including stalking and harassment. The main difficulties she 
described were frequent nightmares and visceral daytime flashbacks of the abuse. She 
reported feeling anxious and hypervigilant, and having poor memory and 
concentration. She also described high levels of guilt and self-blame for not leaving 
the relationship sooner.   
Due to work commitments P4 was unable to attend the Psychoeducation 
group, held during working hours, and instead covered the same material in two 
individual sessions. She was subsequently able to join the CRG group and attended all 
sessions. The end of the CRG coincided with the start of a court case concerning her 
ex-partner.  At the time of analysis P4 had completed 7 sessions of individual 
treatment.  
Generic measures. P4’s scores on measures of depression, anxiety and 
functioning are shown in Table 8. Due to the participant not returning measures, no 
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scores were available for time points 2 or 3. Additionally, since P4 had not yet 
finished individual treatment, no scores were available for time points 9-10.   
Pre-post comparison of assessment and mid-individual PHQ-9 scores 
indicated that P4’s score did not change reliably. Scores on the GAD-7 showed 
deterioration, with scores increasing from the moderate to severely anxious range 
(IAPT, 2011).  On the WSAS P4 showed no reliable change.  Across all three 
measures there appeared to be marked deterioration in the waiting period between the 
CRG and pre-individual treatment (time point 6 to 7).  
Table 8: P4 PHQ-9, GAD-7 and WSAS scores 
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11 - - 15 10 5 15 11 0 N N Moderate 
GAD-7 
 
12 - - 13 9 8 19 17 +5 N N Moderate 
to severe  
WSAS 4 - - 3 13 5 9 6 +2 N n/a n/a 
a
 Reliable Change and Clinically-Significant Change calculated using Jacobson’s Reliable 
Change Index 
Graphical analysis. Results for the PCL-5, Complex PTSD items and FCSRS 
sub-scales scores are presented graphically in Figures 14, 15 and 16 respectively.   
Figure 14 shows P4’s PCL-5 total score, which was 48 at assessment and 43 at 
the mid-individual treatment point, indicating minimal overall change in PTSD 
symptoms from assessment to the mid-individual point.  Due to missing data it was 
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not possible to draw conclusions about the effect of Phase 1. For Phase 2 the trend 
line suggests moderate improvement during the CRG; however, these gains were lost 
in the wait period after (time point 7).  There was insufficient data for Phase 3 to draw 
conclusions; however, the available data for the first half of individual treatment 
suggested slight improvement in PTSD symptoms.  
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Figure 14: P4 PCL-5 Total Score 
Figure 15 shows P4’s scores on the five ‘Complex’ symptom domains of 
CPTSD. Again, missing data made it impossible to draw conclusions about the effects 
of Phase 1. Visual analysis of Phase 2 indicated overall worsening on the Emotional, 
Dissociative and Somatic items, and some improvement for Beliefs and Interpersonal 
symptoms. This suggested that CRG had a minimal impact on CPTSD symptoms. All 
items except Beliefs showed deterioration in the wait period between Phase 2 and 
Phase 3. Four of the five items showed no change in the first half of individual 
treatment. The Somatic item, by contrast, showed improvement. Therefore, the first 
half of individual treatment largely did not appear to impact CPTSD symptoms.  
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Figure 15: P4 Complex PTSD symptoms (BTSS CPTSD items & PCL-5 Item 9) 
Figure 16 shows P4’s scores on the three subscales of the FCSRS. Overall 
there appeared to be no change in scores on Hated Self, Inadequate Self or Reassured 
Self from assessment to mid-individual treatment.  No conclusions could be drawn 
about Phase 1 from the available data. Visual analysis of the trend for Phase 2 
indicated an improvement (reduction) in both Hated Self and Inadequate Self, but 
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only very slight change on Reassured Self. Gains made during the CRG were partly 
lost in the wait period afterwards. The available data for Phase 3 indicated scores 
continued to deteriorate and therefore gains made in Phase 2 were lost in the first half 
of individual treatment. Therefore, for P4, the CRG appeared to be helpful for 
reducing self-criticism, whereas individual treatment was not.  
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Figure 16: P4 FCSRS Subscales: Hated Self, Inadequate Self, Reassured Self 
 
Overall, visual analysis of P4’s data showed little or no overall improvement 
from assessment to mid-treatment on the generic measures, PTSD and CPTSD 
measures or FCSRS ratings. However, the trend did indicate improvement during 
CRG for PTSD symptoms, as measured by PCL5, and for self-criticism, as measured 
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by the FCSRS. Nevertheless, these gains were partly or largely lost during the wait 
period after. It may be important in interpreting these results to note that the post-
CRG period was one of high stress for the participant due to a court case and 
continued threat from her ex-partner, which may have impacted on symptom scores. 
Participant 5 
P5 was a 47-year-old White European woman who was physically and 
sexually abused by her step-father from age 5 to 10.  She also witnessed her step-
father being physically and sexually abusive to her mother. In her mid-twenties P5 
experienced a physically and sexually abusive relationship lasting two years. P5 
described suffering intrusive memories, flashbacks and nightmares linked to both the 
childhood abuse and abuse in adulthood. She had difficulties with relationships and 
avoided sexual intimacy. She described periods of shutting off from others, as well as 
feeling out of touch with her own sense of self. She struggled with regulating her 
emotions, experiencing periods of low mood and angry outbursts. She also described 
considerable self-hatred, self-blame and self-criticism.   She had recently been 
prescribed a tricyclic antidepressant to treat insomnia.    
P5 engaged well with Psychoeducation and CRG.  When starting individual 
treatment, it became apparent that circumstances at home had made it difficult for her 
to practice the techniques learned in the CRG since finishing it, and also made it 
difficult for her to start individual treatment immediately.  After a delay, she 
commenced individual treatment and had had four sessions at the time of analysis.   
Generic measures. P5’s scores on measures of depression, anxiety and 
functioning are shown in Table 9. As she had not reached the mid-point of individual 
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treatment, no scores were available for time points 8-10.  The data indicates that there 
was no reliable change in depression, anxiety or overall functioning scores.   
Table 9: P5 PHQ-9, GAD-7 and WSAS scores 
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PHQ-9 11 18 14 13 17 9 13 +2 N N Moderate to 
moderate 
GAD-7 7 12 10 10 10 2 6 -1 N N Mild to mild 
 
WSAS 14 24 17 23 25 13 20 +6 N N n/a 
a
 Reliable Change and Clinically-Significant Change calculated using Jacobson’s 
Reliable Change Index 
Graphical analysis. Results for the PCL-5, Complex PTSD items and FCSRS 
sub-scales are presented graphically in Figures 17, 18 and 19 respectively.  
Figure 17 indicates that P5’s PCL-5 total score, which was 36 at assessment, 
did not change overall to pre-individual treatment (37). Visual analysis of the trend 
line indicated a slight increase in symptoms during Phase 1 followed by a reduction of 
symptoms in Phase 2, suggesting that the CRG had an effect on PTSD symptoms but 
Psychoeducation did not. Deterioration in symptoms was visible in the wait period 
after the CRG (time point 7). 
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Figure 17: P5 PCL-5 total score 
 
Figure 18 shows P5’s scores on the five ‘Complex’ symptom domains of 
CPTSD. Visual analysis of the five items reveals similar changes on all five items. 
Whilst the lines of central tendency suggest little change between Phase 1 and Phase 
2, the trend lines show deterioration in Phase 1 followed by improvement in Phase 2 
in all five domains. This suggests that Psychoeducation had no positive effect on 
CPTSD symptoms and may even have had a negative impact, whereas the CRG 
appeared to have a positive impact. However, gains in the CRG were partly or wholly 
lost in the waiting period after (time point 7) for Beliefs, Somatic and Dissociative 
symptoms.  
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Figure 18: P5 Complex PTSD symptoms (BTSS CPTSD items & PCL-5 Item 9) 
 
Figure 19 shows P5’s scores on the three subscales of the FCSRS. The trend 
on all three subscales was for little change in Phase 1 followed by moderate 
improvement during Phase 2 (reductions in Hated Self and Inadequate Self; increase 
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in Reassured Self), with the most improvement visible in Inadequate Self, which was 
the highest-scored subscale of the FCSRS at assessment. For Hated and Inadequate 
Self the improvements appear to continue through the waiting period after the CRG, 
but not for Reassured Self. This visual analysis suggests that Psychoeducation did not 
have an impact on P5’s self-compassion as measured by the FCSRS, whereas CRG 
did appear to have a moderate positive impact.  
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Figure 19: P5 FCSRS Subscales: Hated Self, Inadequate Self, Reassured Self 
 
Overall for P5, the generic measures indicated that neither Psychoeducation 
nor CRG were associated with improved symptoms of depression, anxiety or overall 
functioning. Visual analysis of the PTSD, CPTSD and FCSRS scores suggested that 
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Psychoeducation also had little impact on these measures. However, the CRG did 
appear to have a moderate positive impact on PTSD, CPTSD symptoms and FCSRS 
scores. The delay that P5 experienced in starting individual treatment may have 
contributed to the deterioration in PTSD and CPTSD symptoms visible in that wait 
period.  
Participant 6 
P6 was a 44-year-old woman who experienced physical, emotional and sexual 
abuse as a child, and was later in a relationship with a violent partner for 20 years. 
Her PTSD symptoms began in childhood but worsened following the murder of a 
friend ten years prior to assessment.   She was suffering flashbacks, intrusive 
memories and nightmares, daily dissociative episodes, poor sleep and hypervigilance. 
She had some Obsessive Compulsive behaviours, generalised anxiety and depression, 
and unexplained joint pain. She was also having difficulties with relationships with 
others. She held herself responsible for some of the traumatic events and as a result 
she experienced guilt and held beliefs about being deserving of punishment and 
hatred.  The participant had made suicide attempts in the past but had no current self-
harm or suicidal ideation. Prior to treatment at BTSS she had had psychological 
therapy which did not focus on PTSD.  
P6 engaged well with the Psychoeducation and CRG, although there were 
ongoing difficulties with housing and finances over this period. At the time of 
analysis she had had six sessions of individual therapy.  
Generic measures. P6’s scores on depression, anxiety and functioning 
measures are shown in Table 10. As P6 had not reached the mid-point of individual 
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treatment, no scores were available for time points 8-10.  The data indicates that for 
the PHQ-9, GAD- 7 and WSAS P6’s scores did not reliably change from assessment 
to pre-individual treatment, indicating no overall improvement in general anxiety, 
depression or general functioning.  
Table 10: P6 PHQ-9, GAD-7 and WSAS scores 
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PHQ-9 
 
21 18 16 19 17 21 26 +5 N N Severe to 
severe 
GAD-7 
 
17 17 17 18 18 17 18 +1 N N Severe to 
severe 
WSAS 31 32 29 33 32 28 34 +3 N n/a n/a 
a
 Reliable Change and Clinically-Significant Change calculated using Jacobson’s Reliable 
Change Index 
Graphical analysis. Results for the PCL-5, Complex PTSD items and FCSRS 
sub-scales scores are presented graphically in Figures 20, 21 and 22 respectively.  
Figure 20 indicates that P6’s PCL-5 total score, which was 62 at assessment, 
did not improve overall, with the latest score at pre-individual treatment of 63. Visual 
analysis of the graph shows a very slight downwards trend during Psychoeducation, 
however these gains were lost during the wait period after (time point 4) and there 
was no change in trend during Phase 2. The lines of central tendency for Phase 1 and 
Phase 2 were very similar. It was not possible to draw conclusions about Phase 3 in 
the absence of any data beyond the start of individual treatment. Visual analysis of 
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this data suggests that Psychoeducation had a very slight effect on PTSD symptoms 
whereas the CRG had no effect, as measured by the PCL-5.   
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Figure 20: P6 PCL-5 Total Score 
 
Figure 21 shows P6’s scores on the five ‘Complex’ symptom domains of 
CPTSD, most of which she rated highly throughout. The items measuring Beliefs, 
Emotional and Somatic symptoms showed a slight downwards trend (improvement) 
in symptom severity during Phase 1, followed by a stable or upwards trend 
(deterioration) during Phase 2. The phase lines and central tendency for Dissociative 
and Interpersonal symptom items showed that these symptoms stayed stable across 
both Phase 1 and Phase 2. Overall, visual analysis of P6’s data suggests that 
Psychoeducation may have been helpful for CPTSD symptoms, but the CRG did not 
appear to have any effect on symptom scores.  
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Figure 21: P6 Complex PTSD Symptoms (BTSS CPTSD items & PCL-5 Item 9) 
 
Figure 22 shows P6’s scores on the three subscales of the FCSRS.  Visual 
analysis suggests there was little change in these scores across treatment phases, as 
indicated by the similar central tendency in Phase 1 and Phase 2 for all three 
subscales. The phase lines do indicate a very slight decrease in Hated and Inadequate 
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Self and increase in Reassured Self during Phase 1; however, these small gains were 
lost during the waiting period after Psychoeducation and before CRG (point 4). The 
trend line for Reassured Self also indicates a slight increase during Phase 2, although 
again the gains appear to have been lost in the waiting period after (point 7).  This 
data provides limited support for the effectiveness of the Psychoeducation group and 
no support for the CRG building self-compassion and self-reassurance, despite the 
explicit emphasis of the CRG on building these capacities.  
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Figure 22: P6 FCSRS subscales: Hated Self, Inadequate Self, Reassured Self 
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Overall, P6’s scores showed no change on generic measures or on PTSD 
symptoms.  Little overall change was perceptible in the graphical analyses on any 
measures.  Some very slight improvements in CPTSD and FCSRS ratings during 
Phase 1 may suggest that Psychoeducation was helpful; however, in many cases these 
gains were lost in the wait period after. There was little support for the effectiveness 
of the CRG on any measures. According to these results, P6 did not appear to have 
benefited significantly from the treatment programme at the latest available data 
point, although her scores may have been impacted by external stressors (housing, 
finances) that she was experiencing.  
Participant 7 
P7 was a 48-year-old White British woman who experienced an emotionally, 
physically and sexually abusive relationship lasting four years, which involved threats 
to rape and kill. She suffered injuries and attempted suicide before managing to leave 
the relationship 18 months prior to assessment at BTSS. Her PTSD symptoms 
included hypervigilance, panic, dissociative episodes and a heightened sense of threat.  
She had had episodes of low mood and periods of being unable to work. She also 
described difficulty trusting others and feeling cut-off from others, as well as somatic 
complaints. She held negative views of herself, with high levels of shame and self-
criticism. At the time of the assessment a court case regarding her ex-partner was 
pending.  
For P7, Psychoeducation and CRG coincided with her ex-partner’s trial and 
sentencing, and as a result she missed a couple of sessions of both treatment groups. 
At the time of analysis she was due to begin individual treatment.   
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Generic measures. P7’s scores on measures of depression, anxiety and 
functioning are shown in Table 11. As P7 had not reached the pre-individual 
treatment point, no scores were available for time points 7-10.  The data indicates that 
from assessment to post-CRG P7’s depression and anxiety scores showed clinically-
significant improvement, and on the WSAS, P7 showed reliable improvement. 
Table 11: P7 PHQ-9, GAD-7 and WSAS scores 
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PHQ-9 14 20 12 7 11 1 -13 Improve Y Moderate to <clinical 
GAD-7 16 19 18 8 13 1 -15 Improve Y Severe to <clinical 
WSAS 30 30 20 20 24 8 -22 Y n/a n/a 
a
 Reliable Change and Clinically-Significant Change calculated using Jacobson’s Reliable 
Change Index 
Graphical analysis. Results for the PCL-5, Complex PTSD items and FCSRS 
sub-scale scores are presented graphically in Figures 23, 24 and 25 respectively.  
Figure 23 shows P7’s PCL-5 total score, which was 62 at assessment and 
reduced considerably to 16 at post-CRG. Visual analysis of Figure 23 indicated that 
this reduction occurred over both Phases 1 and 2, suggesting that both 
Psychoeducation and CRG were helpful in alleviating PTSD symptoms. Some 
deterioration in symptoms was visible after the wait between Phases 1 and 2 (time 
point 4).  
86 
 
1 2 3 4 5 6 7 8 9 1 0
0
2 0
4 0
6 0
8 0
T im e  p o in t
P
C
L
-
5
P C L - 5
P h a s e  m e d ia n
T re n d
  
Figure 23: P7 PCL-5 Total Score 
Figure 24 shows P7’s scores on the five ‘Complex’ symptom domains of 
CPTSD. In Phase 1 visual analysis revealed a trend of improvement in Beliefs, 
Emotional and Interpersonal symptoms. For Dissociative and Somatic symptoms 
there was overall deterioration in Phase 1, however the graph indicated that this was 
attributable to deterioration in the wait between assessment and Psychoeducation 
(time point 2), and in fact the Dissociative item did show improvement during 
Psychoeducation. All five symptoms showed reductions in Phase 2, suggesting that 
the CRG had a positive impact on CPTSD symptoms.  
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Figure 24: P7 Complex PTSD Symptoms (BTSS CPTSD items & PCL-5 Item 9) 
Figure 25 shows P7’s scores on the three subscales of the FCSRS. The trend 
lines on all three subscales have similar trajectories showing slight improvement 
(reductions in Hated Self and Inadequate Self; increase in Reassured Self) in Phase 1, 
and steeper improvement during Phase 2. This suggested that both Psychoeducation 
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and CRG were helpful, but the CRG was most effective for P7 in reducing self-
criticism and increasing self-reassurance. 
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Figure 25: P7 FCSRS Subscales: Hated Self, Inadequate Self, Reassured Self 
 
Overall, both Psychoeducation and CRG appeared to be associated with 
reductions in P7’s PTSD, CPTSD and self-criticism / self-compassion scores, with the 
CRG phase showing the most marked changes in self-criticism and self-compassion, 
which is consistent with its explicit focus on building self-compassion.  There was no 
data available beyond time point 6 therefore it was not possible to judge whether 
gains made during the CRG were lost or sustained in the wait period after.  
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Participant 8 
P8 was a 23-year-old woman who was sexually assaulted as a teenager, and 
subsequently suffered a controlling and physically abusive relationship for 5 years. 
After separating from her partner she experienced continued harassment by him. P8 
was suffering from frequent nightmares about the abuse, intrusive thoughts and 
feeling anxious and hypervigilant. There was also considerable self-criticism and self-
blame for not leaving the relationship sooner, and the potential impact of the 
relationship on her child.  
P8 attended all sessions of the Psychoeducation group and of the CRG. She 
was obliged to have contact with her abusive ex-partner during this period and legal 
processes were ongoing, which was a source of additional stress.  At the time of 
analysis P8 was due to begin individual treatment.  
Generic measures. P8’s scores on depression, anxiety and functioning 
measures are shown in Table 12. As P8 had not reached the pre-individual treatment 
point, no scores were available for time points 7-10.  The data indicates that P8’s 
scores for depression and anxiety showed reliable change, whereas the WSAS did not 
show reliable change in functioning.   
 
 
 
 
90 
 
Table 12: P8 PHQ-9, GAD-7 and WSAS scores 
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PHQ-9 20 15 16 19 13 14 -6 Improve N Severe to 
moderate 
GAD-7 
 
19 14 13 15 10 8 -11 Improve Y Severe to mild 
WSAS 16 19 17 20 13 13 -3 N n/a n/a 
a
 Reliable Change and Clinically-Significant Change calculated using Jacobson’s Reliable 
Change Index 
Graphical analysis. Results for the PCL-5, Complex PTSD items and FCSRS 
sub-scale scores are presented graphically in Figures 26, 27 and 28 respectively.  
Figure 26 shows that P8’s PCL-5 total score reduced from 66 at assessment to 
40 at post-CRG. Visual analysis of the trend showed a gentle decrease in PCL-5 score 
in both Phase 1 and 2, although the Phase 1 gains are offset by deterioration during 
the wait between Phase 1 and 2 (time point 4). There was not yet data available at 
time point 7 to judge whether Phase 2 gains were lost or sustained in the wait period 
after.  Overall both Psychoeducation and CRG appear to have had a moderate positive 
impact on PTSD symptoms.  
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Figure 26: P8 PCL-5 Total Score 
Figure 27 shows P8’s scores on the five ‘Complex’ symptom domains of 
CPTSD. Visual analysis of the five symptom items revealed different patterns of 
change.  Emotional, Interpersonal and Dissociative symptoms all showed 
improvement from Phase 1 to Phase 2 indicated by lower lines of central tendency in 
Phase 2 than Phase 1. For these symptoms the trend lines indicate there was no 
symptom reduction in Phase 1 but there was in Phase 2.  Beliefs and Somatic 
symptoms showed overall deterioration from Phase 1 to 2, according to the line of 
central tendency, with the trend lines revealing that most deterioration occurred in the 
wait period after Psychoeducation.  Therefore, for P8 Psychoeducation appeared to be 
helpful only for Beliefs, and CRG appeared to be helpful for Emotional, Interpersonal 
and Dissociative symptoms.  
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Figure 27: P8 Complex PTSD Symptoms (BTSS CPTSD items & PCL-5 Item 9) 
 
Figure 28 shows P8’s scores on the three subscales of the FCSRS. Visual 
analysis of the graphs suggested little change across Phase 1 and 2, with no change in 
the lines of central tendency. The trend lines indicate a very slight, negative direction 
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of change (increases in Hated and Inadequate Self, decreases in Reassured Self) in 
Phase 1, and a slight positive trend in Phase 2. Overall, P8’s data offered little 
evidence for the effectiveness of Psychoeducation in reducing self-criticism or 
increasing self-reassurance, but some limited evidence for the effectiveness of the 
CRG.  
0
1 0
2 0
3 0
4 0
In a d e q u a te  s e l f
0
1 0
2 0
3 0
4 0
H a te d  s e l f
1 2 3 4 5 6 7 8 9 1 0
0
1 0
2 0
3 0
4 0
T im e  p o in t
F
C
S
R
S
R e a s s u r e d  s e l f
P h a s e  m e d ia n
T re n d
 
Figure 28: P8 FCSRS Subscales: Hated Self, Inadequate Self, Reassured Self 
 
 Overall for P8 it appeared that Psychoeducation may have been helpful for 
alleviating PTSD symptoms, but not for CPTSD or self-compassion. CRG appeared 
to be helpful for PTSD and some CPTSD symptoms as well as for increasing self-
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compassion. There was no data available beyond time point 6 so it was not possible to 
say whether improvements in the CRG would be sustained in the wait period after.  
Participant 9 
P9 was a 43-year-old White British woman who experienced sexual abuse 
between the ages of 10 and 14, and as an adult was subjected to an emotionally and 
physically abusive relationship lasting 21 years. Additionally, four years prior to 
assessment at the BTSS she also suffered a violent attack resulting in permanent 
injury. She was suffering with intrusions to this attack, to the domestic abuse, and to 
the sexual abuse in childhood. She was struggling with low mood and described 
herself as shutting herself away from the world. She felt lacking in confidence, had 
self-critical thoughts and said she had lost a sense of “who I am”.  P9 had a history of 
self-harm and a suicide attempt, as well as a recent incident of self-harm. She was 
taking an SSRI, a tricyclic antidepressant and pain medication. She was experiencing 
ongoing difficulties with housing at the time of assessment. 
At the time of analysis P9 had completed both Psychoeducation and CRG with 
only one session of each missed, and was awaiting individual treatment.   
Generic measures. P9’s scores on depression, anxiety and functioning 
measures are shown in Table 13. As P9 had not reached the pre-individual treatment 
point, no scores were available for time points 7-10. Due to incomplete questionnaires 
there was only partial data at the pre-Psychoeducation point and no data at the pre-
CRG point.  The data available indicates that overall, P9’s scores for depression, 
anxiety and functioning did not change reliably. 
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Table 13: P9 PHQ-9, GAD-7 and WSAS scores 
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PHQ-9 15 16 12 - 11 17 +2 N N Mod. severe to mod. 
severe 
GAD-7 
 
9 16 7 - 8 13 +4 N N Mild to moderate 
WSAS 19 22 22 - 17 22 +3 N n/a n/a 
a
 Reliable Change and Clinically-Significant Change calculated using Jacobson’s Reliable 
Change Index 
Graphical analysis. Results for the PCL-5, Complex PTSD items and FCSRS 
sub-scales are presented graphically in Figures 29, 30 and 31 respectively.  
Figure 29 indicates that P9’s PCL-5 total score reduced from 51 at assessment 
to 37 at post-CRG, and the line of central tendency indicates lower scores in Phase 2 
than Phase 1. However, missing data at both pre-Psychoeducation and the pre-CRG 
point means caution must be applied in interpreting the relative impact of the two 
treatment groups. From the available data it appears that there was an improvement in 
PTSD score from assessment to post-psychoeducation, and that there was 
deterioration in PTSD symptoms during the second half of the CRG, but there was no 
data for the first half.   
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Figure 29: P9 PCL-5 Total Score 
 
Figure 30 shows P9’s scores on the five ‘Complex’ symptom domains of 
CPTSD. Again, caution must be applied in interpreting the graphs due to missing 
data. Comparisons of the assessment and post-CRG point indicate that the first two 
phases of treatment overall produced a slight reduction in Beliefs and Somatic 
symptoms, no overall change in Interpersonal and Dissociative symptoms, and a 
worsening in Emotional symptoms.   
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Figure 30: P9 Complex PTSD Symptoms (BTSS CPTSD items & PCL-5 Item 9)  
Figure 31 shows P9’s scores on the three subscales of the FCSRS.  All three 
subscales show little change from Phase 1 and 2 according to the lines of central 
tendency, and the trend lines too show minimal change. The available data for P9 is 
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insufficient to provide evidence for the effectiveness for Psychoeducation or CRG in 
improving self-compassion. 
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Figure 31: P9 FCSRS Subscales: Hated Self, Inadequate Self, Reassured Self 
 
Overall the available data for P9 indicated that the two phases, 
Psychoeducation and CRG, taken together, did not have much of a positive impact on 
generic measures or on CPTSD or FCSRS scores, but they were associated with 
moderate improvements in PTSD symptoms. Missing data made it impossible to 
extrapolate any differences in impact of Psychoeducation and the CRG.  
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Summary. The findings of the case series illustrated the differential responses 
of nine participants undergoing the same treatment programme. The majority of 
participants showed some areas of improvement over the course of treatment, with P6 
the only non-responder in any phase on the PCL-5 and the generic measures, though 
she did show some improvement in self-compassion. It may be relevant to note the 
considerable co-morbidity that this participant presented with (OCD and generalised 
anxiety symptoms additionally to CPTSD), as well as the extreme chronicity of her 
traumatic experiences, which included abuse in childhood, IPV spanning twenty years 
in adulthood, and a traumatic bereavement.  
Although all other participants showed improvement on at least some 
measures, pre-post analysis of PTSD symptoms indicated that some participants (P1, 
P2, P3, P7, P8) made reliable, clinically-significant improvement while others did not 
(P4, P5, P6, P9). There did not appear to be any specific trauma background 
characteristics that marked out the higher responders from the lower responders. 
Longitudinal data presented graphically revealed that participants experienced 
differential changes in symptoms in differing phases of treatment. These differences, 
which are apparent at an idiographic level, would risk being obscured at a group-wise 
level of analysis.  
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Chapter 4: Results of Thematic Analysis 
A second, qualitative analysis was carried out consisting of a thematic analysis 
of interviews with a further six participants, all of whom had completed all three 
phases of the treatment programme.  See Table 14 for participant characteristics. 
Participants were between 22 and 52 years old (mean = 41.5) and had completed the 
treatment between one week and five months prior to the interview (mean = 8 weeks).  
Table 14: Thematic Analysis Participant Characteristics 
ID Sex Age Trauma type Time since 
completing 
treatment 
10 F 48 Child physical and emotional abuse. Violent sexual 
attack in adulthood in context of intimate partner 
violence. 
1 week 
11 F 22 Child physical abuse and witnessed violence. Sexual 
assault 2 years ago by multiple perpetrators. 
5 months 
12 F 52 Child sexual, physical abuse and torture by multiple 
perpetrators. 
1 week 
13 F 50 Two sexual assaults by same perpetrator, 3 years ago. 4 weeks 
14 F 35 Sexual assault at age 13 and intimate partner violence 
in adulthood in several relationships, one occasion 
resulting in miscarriage. 
6 weeks 
15 M 42 Child sexual, emotional and physical abuse from age 2. 3 months 
 
Complete transcripts of all six interviews were included in the thematic 
analysis. The analysis was conducted according to the six-phase procedure set out by 
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Braun and Clarke (2006) for thematic analysis, and adhering to the 15-point checklist 
of criteria that the authors propose for good thematic analysis. The data were 
transcribed using a simple orthographic notation which is recommended for thematic 
analysis since it does not require the same level of detail in the transcript as discourse 
or narrative analysis (Braun and Clarke, 2006). Immersion in the data began during 
transcription and with repeated readings of the data corpus. Coding and recoding was 
facilitated by using the qualitative analysis software package Atlas Ti.6. Within Atlas 
Ti.6 each interview transcript was assigned to a separate primary document within the 
hermeneutic unit.  See Appendices K and L for samples of coded transcripts. 
The analytic process was theoretically-driven, meaning that the researcher was 
reading for interesting meanings and patterns specifically relating to the acceptability 
of the treatment programme.  This approach to thematic analysis is recommended for 
answering a specific research question and providing a detailed account of a specific 
aspect of the data corpus, rather than an inductive approach which aims to code freely 
without any pre-existing coding frame or theoretical stance (Braun and Clarke, 2006). 
The analysis was semantic, in that, unlike, discourse analysis, the analysis did not 
seek to theorise about underlying conceptualisations or ideologies; language was 
assumed to straightforwardly reflect participants’ meaning and experience.  
The data corpus was actively read, searching for interesting meanings and 
patterns relating to participants’ experience of treatment, and was coded in a 
systematic fashion, collating codes into candidate themes. These themes were checked 
across the data set and refined until they were considered an accurate reflection of the 
meanings evident in the entire data set.  
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The analysis yielded two main, overarching themes in the data relating to the 
acceptability of the treatment programme: ‘Experience of group treatment’ and 
‘Experience of phase-based treatment’. These themes and their sub-themes are 
described and illustrated using extracts from interview transcripts. 
Experience of Group Treatment 
All participants talked about their experience of treatment delivered in a group 
format. Participants tended not to distinguish between the experience of being in a 
group for Psychoeducation and the experience of being in a group for the CRG. 
Within this theme the following three sub-themes were identified: ‘Group as “the 
biggest anxiety”’, ‘Group as “helping each other out”’, and ‘Group “makes you feel 
normal”’.   
‘Group as “the biggest anxiety”’. This sub-theme was identified in 
participant’s descriptions of their expectations and fears before starting the treatment 
programme, and related to the group format being, for many participants, an off-
putting element to the treatment; for some, the most off-putting element. In all cases, 
however, it was described as an anticipatory worry which did not materialise. This 
sub-theme is illustrated by the following extracts from interview transcripts: 
“I think it’s fair to say that we were all really scared, to say the least, in 
walking in and all sort of sitting around each other” (P11, para. 22) 
“I mean I was, in the beginning I was really quite apprehensive about that, 
you know, other people being there, but no, it worked well for [phase] one and two I 
think.” (P13, para.65) 
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For many participants the anxiety about being in a group was related to a fear of 
judgement from other group members, as in the following extract:  
“I had concerns about opening up, and um worrying about what I would have 
to talk about, what had happened to me, or how I felt, and about people judging me, 
both the consultants and the other people being in the group, so I think the biggest 
anxiety was meeting the other people in the group and what they would think, but 
actually when you meet the people in the group you’re not talking about yourselves at 
all” (P12, para. 9) 
The risk of judgment for most participants, like P12, was rooted in a fear of being 
judged negatively by other group members for features of their personal lives or 
trauma history. For one participant with a history of intimate partner violence, the fear 
of being judged also related to being judged as non-deserving of the treatment:  
“I thought oh crap, here we go again, everyone’s going to go ‘you’re a bloody 
fraud, you could have just walked away, why didn’t you do this’, and you know that, 
that was a big fear that someone was going to turn round and almost tell me off for 
being there. R:  And did anything like that happen? P14: No, no! [laughs]” (P14, 
para.43) 
The same participant later described how this anxiety about disclosing her trauma 
history to other group members was overcome with time: 
“We didn’t need to go into anything specific, um, I think some of us did 
occasionally, very broadly speaking we went into things, but again I started to get 
over that fear of people judging me as much, and started to actually open up a little 
bit about it in the group, and yeah I mean, the other women all seemed to jump on the 
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bandwagon of going ‘no, of course you deserve to be here’ and stuff like that which 
helped massively.” (P14, para. 73) 
Several participants, as for P12 and P14 above, talked about how their pre-
treatment fears of being judged by others in the group did not materialise partly 
because personal disclosure of trauma history in the group was restricted by pre-
agreed group boundaries and managed carefully by facilitators; the importance of this 
was illustrated in the following two extracts: 
“There was still confidentiality there as well, because as much as we all got 
really close we all actually didn’t know exactly what that other person went through, 
so that was still quite nice because you didn’t know what they were going to think 
about you if you were going to be embarrassed over it or anything” (P11, para.35) 
 “I think once we established like from the very very first moment we 
established that we’re not actually there to talk about anything that’s happened to us, 
that made it a lot easier.” (P14, line 19) 
In addition to fear of judgement from others, another concern about the group 
format mentioned by some participants was the potential negative impact of having to 
hear others’ disclosures, as in the following extract. Again, this issue was seemingly 
managed by limiting disclosure about traumatic experiences within the group.   
“I think it’s just the anxiety of realising, uh, worrying what other people think 
and I think it will be that that stops people going to it, because you’re going to a 
group and you’re thinking that you’re going to be there hearing about other peoples’ 
awful stories and you won’t cope with listening to that… and you don’t know what to 
do because you’re not a practitioner so you can’t support them or give them any help, 
105 
 
but it’s absolutely nothing like that…  because if you’re listening to other peoples’ 
stories and you’re already weighed down with what’s happened to you, you could 
then, um, it could tip the balance with you because you’re not able to do anything to 
help them.” (P12, para.13) 
This theme highlights how anxiety-provoking the group format can be for clients 
before starting treatment, and illustrates some specific concerns that clients may have. 
However, it also indicates that most of the concerns raised by the participants about 
group treatment were adequately addressed through the careful setting up and 
facilitation of the group in relation to self-disclosure.  
‘Group as “helping each other out”’. This second sub-theme relates to 
participants’ descriptions of how members of the group would help each other, both 
within sessions and outside of sessions. Some participants talked of being helped by 
others in the group, some of helping others, and some of both. Two of the ways in 
which participants described being helped by others in the group in a co-therapist type 
of role was by generating new ideas and more compassionate perspectives for each 
other, as in the following two extracts: 
“And the fact it was done in a group, you helped each other in different 
situations because you all have gone through different things but you can all 
sympathise and have empathy, and maybe see around, a way that somebody can 
probably do something different. And I think that that was the biggest thing in the 
group, for me…. again it was helping each other out in situations that arose in 
everybody’s week”. (P10, para. 9) 
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“It started me on the path of trying... to stop listening to that negative voice 
and to try and get a more positive one in my head. It started that process. And even 
though it wasn’t my voice I could hear the voices of the other girls in the room telling 
me that I was, you know, that I wasn’t allowed to speak to myself in that way and 
stuff, so, it did help in that regard, it gave me a different internal dialogue even 
though it wasn’t mine!” (P14, para.79) 
These examples illustrate an advantage of group format over individual format, in that 
it offers more peoples’ perspectives than individual therapy can. Another participant 
spoke of being helped by the presence of others in the group because they, by having 
some commonality of experience, were able to give a voice to some of her own, more 
difficult to articulate, thoughts:  
“As the weeks went on and we got to know one another, um, things that other 
people were saying, you know, I may have been thinking that, and wanting to speak, 
but didn’t want to speak, and then somebody else would say it for me, and I would 
think ‘well, I was going, I wanted to say that’ but my mouth wouldn’t open and the 
words wouldn’t come out. So, yeah, they were, we were all on the same wave band 
and thinking more or less the same things.” (P13, para.33) 
Another participant talked about the way in which group members would offer each 
other comfort during difficult sessions, an experience which she described as 
simultaneously ‘horrible’ and working ‘really, really well’.   
“It was horrible sitting back and watching somebody that you have grown 
close with getting really upset, but at the same time you were kind of happy that you 
were there so that when they were going through that, getting their flashbacks or 
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anything, that you were comforting them. I think they also really wanted that comfort 
as well. So all in all it worked really, really well.” (P11, para.24) 
This extract points to the fact that helping others in the group was positive overall but 
could also be experienced as a responsibility. Whilst the above extracts are examples 
of group members helping each other within sessions, several participants also 
described the group members helping each other by providing support outside of 
treatment sessions, as illustrated by the following two extracts:  
“Um, and being in a group as I said on the weeks that we couldn’t have a 
session we were all meeting up and trying to be there for each other as much as we 
could, and no, I think that made a massive difference, it made us have that sort of 
camaraderie between us a bit which was good.” (P14, para. 73) 
“We all used to go out to a coffee shop afterwards and sit and have coffee 
together and just, laugh it off you know, especially if it was a really upsetting session 
then we’d all have a nice hot chocolate and just sit and try and giggle it all off.” (P11, 
para. 35) 
It appears that for Participant 11 the social element offered by the group acted as a 
sort of cathartic ‘bridge’ between the emotional intensity of the treatment sessions and 
the outside world. The social aspect of the group was clearly important to several 
participants. As the following extract indicates, this tended to develop gradually over 
a few sessions: 
“We all got on pretty well and it, you know, after a few weeks we all started to 
talk and chat and before we went in you know the class we would be chatting outside, 
so it was quite nice having other people in the group.” (P13, para.65) 
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This sub-theme therefore demonstrates the varied ways in which participants 
experienced the group as helpful, inside and outside of sessions, both in terms of 
therapeutic support, and in terms of providing social relationships that are sometimes 
lacking for people with CPTSD.  
‘Group “makes you feel normal”’. This sub-theme related to the ways in 
which participants said being part of a group helped to change their view of 
themselves, their emotions or their symptoms, in a normalising way. The following 
extract illustrates how the other group members made one participant feel differently 
about his own emotions, and that this in turn changed how he saw himself: 
 “R: What do you think made the groups a bit more helpful for you than 
individual work? P15: Um, sharing each other’s emotions and their troubles, because 
you feel so isolated, you honestly feel that you are the only one on this planet with all 
these problems, you know, that’s how it makes you feel, you know, and when you hear 
other people’s stories, and see how angry and emotional they are, you know, it makes 
you feel, you know, it’s difficult for you to understand, but, it kind of makes you feel 
normal. You know, it makes you feel like, I’m not going crazy, I’m not an alien, you 
know, I’m not the only one in the world with this, you know.” (P15, para. 105) 
This participant points to both the emotional dysregulation and negative beliefs about 
the self that are characteristic of CPTSD, but also the isolating experience of having 
mental health problems, and how a group can alleviate this isolation and make you 
feel more ‘normal’. Another participant talked about the importance of being treated 
with respect by other group members, as well as the experience of having her own 
emotions validated by others:  
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 “I think we all had that same respect because we all came here knowing that 
we’ve all suffered and that it’s hard. So just that respect that was shown, not just 
through the facilitators but everybody involved. So the respect and validating your 
emotions was good.” (P10, para.27) 
The significance to P10 of being treated with respect by other group members perhaps 
points to previous experiences of not feeling respected by others, or not feeling 
worthy of respect. This may be related to having experienced abusive relationships, or 
to the societal stigma that people with chronic mental health difficulties often 
experience. The following participant talked about how meeting other people who had 
similar struggles with mental health helped her to feel less ashamed of her own 
difficulties, after a lifetime of stigmatisation:  
“And yeah, just having the reassurance that there were other people going 
through it as well, that you’re not on your own, because everything prior to that point 
had always been very hushed up, and you know, I’m nearly [age] for god’s sake and I 
started in mental health when I was twelve, you know, and it was the dirty family 
secret, you know. And this just made it open, and the fact that there were other people 
sat there with me and, you know, some of them were my age, some of them were 
younger than me, but I think we’d all to some extent experienced that ‘oh it’s a dirty 
secret and you’re on your own and you’ve got to cope with it on your own and you’ve 
got to be silent about it’. (P11, para.29) 
The same participant went on to talk about how being amongst others who had had 
similar experiences allowed her to be freely herself in a way she couldn’t with people 
outside of the group without fear of being seen as mad: 
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“It was something to actually really look forward to because in our own 
heads, you know, especially with our family and friends who are closest to us that 
knew us all thought to a certain extent that we were a bit cuckoo, and uh, [laughs], 
having that one time a week where we could actually thoroughly be ourselves was 
probably the highlight of everyone’s week.” (P11, para.35) 
This sub-theme therefore demonstrates how powerful the experience of being in a 
group could be, perhaps particularly for those who carried strong negative beliefs 
about themselves or about their mental health, and how being enabled to feel more 
‘normal’ and acceptable was an important part of the treatment in its own right.  
Experience of Phase-based Treatment 
This theme described participants’ experiences of the structure of the 
treatment programme as a whole, the sequential design, and the relationships between 
the three phases.  Two sub-themes were identified: firstly, ‘Phases “work as a 
package”’, and secondly, ‘“Whipping off the band-aid” – the difficulty of wait 
periods’. 
Phases ‘work as a package’. This theme related to participants’ perceptions 
that all three stages of the treatment were complementary, or that there was a sense of 
progression across the phases and that this made sense to them. Several participants 
expressed the view that they didn’t feel the treatment would work without all three 
phases, as in the following two extracts:  
“R: And, overall, with the three phases, do you have a sense of which one was 
the most useful for you? P15: No, I wouldn’t just pick one because I think it works as 
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a package. If you took one out, I don’t think it would work. I think you kind of need all 
of that, to make it work.” (P15, para.157) 
 “I don’t think you could recover in the way that I recovered, and I have really 
recovered, you know, I don’t have any nightmares any more, I don’t suffer from 
anxiety in the way I did, you know, I just don’t have the symptoms I had before. So, 
that wouldn’t have worked if I hadn’t done all three phases….  Each phase was very 
different to the other, so there was a little bit of similarity or understanding the 
second phase with the first phase, you’d think ‘Oh I learnt that, I understand that 
now’ but I can’t imagine how you could do it any other way. It was very, very 
thorough, and very, very effective.” (P12, para.48) 
This sense of each phase offering something different was echoed in the following 
extract, where a participant articulated very clearly what she felt each phase had 
uniquely offered:   
“R: And do you think any of the phases were more helpful than the others, 
would you say?  P13: Um, well for me personally the first one because the 
understanding of an illness was helpful. And the second, yeah, all of it the same I 
suppose, yeah the second one was helpful because I learned not to blame myself for 
what happened, and the third one because I spoke out and said something that I really 
needed to say. So to me they all, yeah there was something in each of them that did 
help me.” (P13, para.96) 
Many participants talked about the sequential nature of the phases of treatment, 
whereby they felt that the order of the phases was appropriate and meaningful. In the 
following extract the participant compares this to learning to read by learning the 
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alphabet first, giving a strong sense of the treatment as building in complexity across 
the phases: 
“The first phase, you couldn’t have done any of it without doing it, you had to 
do the first phase to do the second phase to get to, to get what you needed to out of the 
second phase, um. I can’t remember any of it in detail, but just one automatically 
went onto the other. It’s like learning to read and write without learning the alphabet, 
you couldn’t do it” (P12, para.19) 
In the following extract P14 describes how the first phase of treatment, 
Psychoeducation, helped her in the second and third phases by helping her to identify 
new ways of coping with traumatic memories, and to reduce less helpful coping 
strategies: 
“But definitely me understanding my symptoms more helped me protect myself 
a bit more when it did come to the second stage and the third phase when I actually 
started bringing up a lot more old memories and stuff like that, having that protection 
of understanding ‘well yeah, if I wear pyjamas in bed I’m going to feel safe’, ‘if I do 
this I’m going to feel better’, and um, you know. And it helped me make a decision as 
well that, during that period I went ‘right, I’m going to take my drinking in hand 
because obviously this isn’t making it any better’… yeah it definitely helped quite a 
lot I think because it sort of set down the foundations for me being able to then go to 
the next point. (P14, para.55) 
A number of participants talked about the treatment being sequential 
specifically in terms of how the earlier two phases had helped them in preparing for 
Phase 3, individual trauma-focused therapy, by developing the resilience necessary 
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for getting through what was often perceived as the most difficult phase of treatment. 
In the following extract, P11 talks about having built up both ‘tools to cope’ and 
confidence in the first two phases that helped her with the third phase.  
“P11: You felt like going into that final third phase you had enough tools to be 
able to cope with whatever was going to hit you, as such… R: How do you feel it 
worked having the treatment in three different phases?  P11: I thought it was 
brilliant. Because as much as they were all sort of very very different, they all pieced 
together quite well, and I think going through the third and final stage which was the 
hardest stage um, having the group therapies to begin with helps build your 
confidence for when going into that third phase” (P11, para.45) 
In the following extract, the participant sees Phases 1 and 2 as necessary not just for 
building coping skills but also in reducing the risk of triggering self-harm, and in 
building the trust necessary to engage in Phase 3: 
 “R: Did you find any of the phases particularly more helpful or less helpful 
than the others? P12: They were all crucial, but the final phase was the final 
recovery, doing those stories. But I couldn’t have done those stories if I hadn’t, if the 
trust hadn’t built up. R: So it would be difficult doing phase 3 without having done 
phases one and two? P12: You wouldn’t be able to do it. It would be too dangerous. 
And those might be stupid words to say! But it would have been too dangerous really. 
You wouldn’t have been able to attempt that, I think you could end up having people 
walking out and actually, reliving something like that, you could end up with people 
being suicidal I think, or attempting suicide.” (P12, para.55) 
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Whilst many participants did not identify one phase as more helpful than the others, 
those who did largely identified the third phase as the most useful to them overall. 
However, they also talked of how difficult it might have been to do the individual 
trauma-focused work without doing the other phases first, as in the following extracts. 
These participants perceived the first two phases as primarily designed to help with 
coping in Phase 3 of the treatment.  
“[Phase] three I think really helped me more than the other two. Because it 
enabled me to gain control. Whereas the other two was just learning about how to 
deal with this third phase. But the third was, ‘you’re taking control of your life now, 
you’ve done the prep for it, we’ve put everything in place.’” (P10, para.95) 
 “I would say the third phase made the most difference, but if I hadn’t gone 
through the first two I wouldn’t have been able to just even have coped with the third 
phase. I think we would still be there now, going over the same memories, you know, 
hashing through it over and over again, and I wouldn’t be moving anywhere with it, 
I’d still be stuck on repeat where I had been for the last twenty-two years before I 
started this process, you know.” (P14, para.91) 
This sub-theme therefore illustrates the broad perception amongst the participants that 
the three phases of the treatment worked together in a complementary fashion, and 
were all helpful towards recovery. Further, that the order of the phases had an 
underlying logic, and this underlying logic was often perceived as being to help 
participants to engage with trauma-focused therapy in Phase 3, which these 
participants felt it had done.  
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 ‘“Whipping off the band-aid” – the difficulty of wait periods’. This sub-
theme reflects participants’ experiences of the two wait periods between the three 
phases of treatment. The theme takes its name from the following extract where a 
participant talked about the anxiety she experienced waiting between one and two 
months after Phase 2 (CRG) to start Phase 3 (individual trauma-focused therapy): 
“P14: I mean it was getting towards being a bit long but it wasn’t too bad, 
you know. I think, you know, if you get to that point where it’s been more than a 
month you start going ‘ooh, do I really want to do this?’ Because also you’ve got that 
fear and the knowledge that you know, you know that you’re about to have to go 
through everything, and yeah. R: Mm, so there’s something about getting onto it 
quickly? P14: Mm. Whipping off the band-aid, yeah!” (P14, para.103) 
The expression ‘whipping off the band-aid’ captures a sense of trying to minimise 
pain by moving quickly onto the third phase, and the pain in question seems to be the 
anxious dread of trauma-focused therapy.  Other participants also spoke of finding 
this wait between CRG and individual therapy particularly difficult.  
 “P11: I think there was a bit, yeah there was a bit of a wait in going from um 
the second phase to the third phase. R: How did you find that?  P11: It was, it was a 
little bit distressing as such, because I felt like I had done so well, and accomplished 
so much in the first phase and the second phase that I was so ready to go onto the 
third one, and that wait in between I felt like yeah I had a certain amount of tools to 
cope, but I wasn’t quite there yet, and it was still affecting my everyday life and the 
things that I did, that I just so badly wanted it over” (P11, para.48) 
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The participant refers to the waiting period before Phase 3 as ‘distressing’ and seems 
to refer to the third phase of treatment when she talks of wanting it ‘over’. For other 
participants, the difficulty of wait periods wasn’t merely caused by anxious 
anticipation of Phase 3, but also having to cope without any therapeutic contact, 
having become accustomed to weekly contact in Phases 1 and 2: 
“R: How were those breaks for you? P13: Um, I panicked a bit because um, it’s like, 
not seeing anybody to say how I’m feeling, you know the questions that you’re asked 
in the class, um, about your feelings and how you felt inside and stuff, to the weeks 
that I didn’t see anybody for that it was a bit unnerving, like ‘how am I going to cope 
until my next meeting?’ But then if it was quite a long break as the weeks went on it 
did get easier, um. R: But it was tricky? P13: Yeah, because I didn’t have no one 
there.” (P13, para.87) 
It is not clear whether the participant is referring to the loss of the group facilitator or 
the other members of the group; it seems that what is important is simply contact with 
someone who is interested in her wellbeing.  
For other participants, what made the idea of longer wait periods anxiety-
inducing was the fear that the progress they had made in treatment so far might be 
compromised, as in the following extract: 
“I think there was, you always had that fear there was going to be a big break 
in between each phase, uh, because there was always that possibility. I think I was 
quite lucky in the fact that that didn’t really happen to me. But if there had been too 
big a break you feel like you might have stepped backwards before you’d managed to 
get up onto the next level, you know.” (P14, para.99) 
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The following participant expresses this fear of losing what she has gained by 
forgetting the previous ‘course’, as well as echoing some of the same concerns as 
above about managing anxiety about Phase 3: 
“P10: Between the first and the second that wasn’t too bad. But then second 
and the third it was scary, because it’s like ‘what are you going to have to go 
through? What’s it going to be like?’ And I think the three to four weeks was quick. 
The fact that I’ve done these three courses in less than a year and the fact that they 
were open to me that quick, that saved me another year of suffering. R: So you were 
glad to move on reasonably quickly?  P10: Yeah because then you don’t forget the 
previous course.”  (P10, para.91).  
It is notable that P10, as for P14 above, spoke about a hypothetical scenario of having 
a long wait period, and how that would be difficult, whilst saying that the wait periods 
she herself experienced were manageable in length. This suggests that the wait 
periods between treatment phases, which are self-evidently not the main focus of the 
treatment design, are nonetheless a psychologically-significant element of the phase-
based structure, even for those who have short wait periods, because of the feelings of 
isolation or worry that they may provoke. Further, the analysis suggests that longer 
waits between Phase 2 and 3 in particular may be difficult due to the anxiety attached 
to starting trauma-focused therapy. 
Summary. The themes and sub-themes of the thematic analysis indicated that 
both the group format of Phases 1 and 2 and the phase-based structure of the 
treatment were acceptable to the interviewees, who described various ways in which 
they helped in their recovery. However, it also demonstrated the ways in which both 
could be cause for anxiety: anticipatory anxiety of attending a group for the first time, 
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or anxiety about the wait periods between the treatment phases. The ‘Group as “the 
biggest anxiety” sub-theme also demonstrated the importance of careful management 
of disclosure within the group by the facilitators, which the participants in this 
analysis appeared to feel had been achieved.  
The theme ‘Experience of phase-based treatment’ also provided some insight 
about how the third phase was experienced by participants: for several participants it 
was the most helpful phase of the treatment, as well as the most difficult. This offered 
a perspective on the third phase of the treatment for which there was less data in the 
case series analysis. Although the samples for the two analyses were different, they 
were triangulated to provide some evidence for both the effectiveness of the treatment 
for the majority of participants in terms of symptom reduction, and the acceptability 
of the treatment programme.  
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Chapter 5: Discussion  
This study sought to evaluate a new phase-based treatment for CPTSD 
through two separate analyses: a case series analysis of outcome data to evaluate 
effectiveness, and a thematic analysis of qualitative interview data to evaluate 
acceptability.  The case series broadly demonstrated that the treatment was effective 
for most participants, but patterns of change differed between participants. The 
thematic analysis suggested that participants experienced the treatment programme as 
highly acceptable and appropriate to their needs, although it was associated with 
anticipatory anxiety, particularly around the group format of Phases 1 and 2. 
Effectiveness of the Treatment Programme  
The case series analysis provided detailed, longitudinal data for nine 
participants from assessment to end of Phase 2 or later, using measures of PTSD 
symptoms, CPTSD symptoms, and levels of self-compassion. All nine participants 
had CPTSD from either childhood abuse or adult intimate partner violence, in some 
cases both, and several had ongoing stressors at the time of treatment, such as court 
cases.  
Whereas eight of the nine participants were above a clinical cut-off of score of 
44 on the PCL-5 at Assessment, only three participants were still above the cut-off at 
Post-CRG, falling to one at the latest available data point. Of the six participants 
below clinical cut-off at Post-CRG, three also met criteria for reliable, clinically-
significance change. This indicated that the treatment programme was effective in 
treating PTSD symptoms; further, that the first two phases were effective for some 
participants, without any trauma-focused therapy. Additionally, since using the latest 
available data for pre-post analyses resulted in higher rates of remittance than at Post-
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CRG, it is possible that, had the analysis been able to follow all participants to the end 
of treatment, symptoms would have further improved.  
The rate of improvement in PTSD symptoms at the latest available data point, 
with eight participants being in the sub-clinical range for PTSD, compares favourably 
with existing phase-based treatments for CPTSD. In the evaluation of STAIR 
followed by prolonged exposure (STAIR-PE; Cloître et al., 2002), 77 per cent of 
participants who received the STAIR–PE condition, did not meet criteria for PTSD at 
post-treatment.  
Pre-post analysis of PCL-5 scores at post-CRG, which found that six 
participants were below clinical cut-off and three had made reliable, clinically-
significant improvement, provided a comparison point with other stabilising 
interventions evaluated in isolation, such as Dorrepaal and colleagues’ pilot study 
(Dorrepaal et al., 2010). This was a 20-week stabilising group intervention comprising 
of psychoeducation and CBT principles, designed to treat CPTSD related to childhood 
abuse. The authors found that 22 per cent of participants who received the 
stabilisation intervention alone, without subsequent trauma-focused therapy, no longer 
met criteria for PTSD at post-intervention, as measured by SCID-1, rising to 35 per 
cent at follow-up. The first two phases of the present treatment programme therefore 
compare favourably to Dorrepaal’s stabilising intervention, as measured by changes 
in PTSD symptoms.   
Despite this overall positive picture of improvement, which suggests that the 
treatment is effective at reducing PTSD symptoms, graphical analysis revealed 
considerable heterogeneity in patterns of change between participants and between 
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measures. These will be considered in further detail for each phase, in relation to the 
specific hypotheses of this study.  
Phase 1: Psychoeducation 
It was hypothesised that no change or only small spontaneous changes in 
PTSD and CPTSD symptoms would occur over Phase 1, Psychoeducation, since its 
aim is to educate rather than to treat symptoms.  This hypothesis was partly confirmed 
by visual analysis of case series data, although the heterogeneity of the data made 
drawing conclusions about Psychoeducation from this sample difficult. 
Psychoeducation appeared to have helped some participants, but not all.  Of the seven 
participants for whom there was discrete Phase 1 data, four participants appeared to 
show reductions in PTSD severity during Psychoeducation; however, for three of 
these, gains made during Psychoeducation were partly or wholly lost in the wait 
period afterwards. There was a similar picture for CPTSD symptoms. Three of the 
seven participants showed improvement on at least three of the five CPTSD symptom 
items during Psychoeducation, however, only one participant maintained these gains 
during the wait period after. 
The case series findings therefore provided only limited evidence for the 
effectiveness of Psychoeducation in reducing PTSD or CPTSD symptom scores. 
Whilst this may call into question the utility or necessity of the intervention, it is 
possible that Psychoeducation may perform a function that is not assessed by the 
outcome measures used here. In a study of a 10-week psychoeducation group 
intervention for survivors of CSA, Karatzias et al. (2014) found no changes in PTSD 
symptomology, depression, anxiety or self-esteem, as measured by outcome 
measures; they did however find lower rates of self-harm, decreased rates of smoking, 
122 
 
alcohol and substance misuse, as well as lower involvement in illegal and antisocial 
behaviours at post-treatment and follow-up. This suggests that psychoeducation 
interventions may offer positive aspects of stabilisation that are more difficult to 
capture through standardised measures, or may be less immediate, and therefore not 
seen in Phase 1 scores.  
Additionally, although the sample of participants was different for the two 
analyses, it is relevant to note that the findings of the thematic analysis indicated that 
participants found all three phases of the treatment programme helpful, and that they 
worked together as a package, in a logical, sequential fashion. Some participants 
described Phase 1 as giving them an essential level of understanding about their 
difficulties, and said that they didn’t feel the treatment would have worked as well as 
it did if any of the three phases had been removed.  
Phase 2: Compassionate Resilience Group 
The second hypothesis of this study was that differential change would be 
evident over Phase 2, the Compassionate Resilience group (CRG), with a greater rate 
of reduction in CPTSD symptoms than in PTSD symptoms, as well as improvements 
in self-compassion. This was predicted because CRG is a non-trauma-focused 
intervention designed to target the ‘complex’ items of CPTSD, such as emotional 
dysregulation, interpersonal difficulties and negative beliefs, by building self-
compassion and reducing shame, rather than targeting core PTSD symptoms.  
Changes in PTSD and CPTSD symptoms. Of the eight participants for 
whom there was discrete Phase 2 data, visual analysis indicated that seven 
participants showed improvements on some or all measures over Phase 2, indicating 
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that the CRG was helpful for almost all participants. Of the eight participants, six 
showed improvements on at least three of the five CPTSD items. Whilst not all 
participants showed improvement on all five items, decreases were visible for all five 
items – beliefs, emotional, interpersonal, dissociative and somatic – across the nine 
participants during Phase 2, indicating that the CRG may be effective for the range of 
additional ‘complex’ symptoms that are believed to make up CPTSD.  
Contrary to the hypothesis, however, there was no evidence for a greater rate 
of reduction in CPTSD symptoms than in PTSD symptoms in Phase 2. Of the six 
participants who showed improvements in CPTSD symptoms during Phase 2, all six 
also showed improvements in PTSD symptoms, as measured by the PCL-5. One 
participant did not show improvement on CPTSD items but did show improvement on 
the PCL-5.  
Therefore, the evidence suggested that the CRG was effective in reducing 
CPTSD symptoms for six of the nine participants. It also, contrary to the hypothesis, 
showed similar benefits for reducing PTSD symptoms. This was not predicted, given 
that the CRG targets self-compassion rather than core PTSD symptoms and it does 
not involve trauma-processing, which is the NICE- recommended component of 
evidence-based treatments for PTSD.   
This finding lends tentative support to arguments that shame and deficits in 
self-compassion serve to maintain PTSD symptoms, and that, therefore, 
improvements in self-compassion may reduce PTSD symptoms (Lee, Scragg and 
Turner, 2001). This is consistent with a recently published study of within-person 
processes of 65 participants undergoing exposure-based cognitive therapy for PTSD 
by Hoffart, Øktedalen and Langkaas (2015), where PTSD symptoms and self-
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compassion were measured weekly. The authors found that the self-compassion 
components of self-kindness, self-judgment, isolation, and over-identification had a 
within-person effect on subsequent PTSD symptoms, with reduction in self-
judgement particularly significant. By contrast, they found few indications that 
within-person variations in PTSD symptoms predicted subsequent self-compassion.  
Changes in self-compassion. The second part of the hypothesis was that 
Phase 2 would show improvements in self-compassion, as measured by the FCSRS. 
This was predicted because the explicit focus of the CRG is on building self-
compassion and reducing shame. This hypothesis was supported by visual analysis of 
the data, which showed that seven of the eight participants for whom there was 
discrete Phase 2 data experienced improvement on at least two of the three subscales 
of the FCSRS.  
For those participants who showed improvements on the FCSRS in Phase 2, 
most showed the steepest apparent improvement on the Inadequate Self subscale, with 
five participants showing marked improvement on this subscale. The case series data 
therefore appeared to provide evidence for the CRG as an intervention that effectively 
addresses self-criticism.   
Phase 3: Individual Trauma-Focused Therapy 
Finally, it was predicted that in Phase 3, individual trauma-focused therapy, 
there would be a greater rate of reduction in PTSD symptoms than in CPTSD 
symptoms, since Phase 3 consists of evidence-based treatments for PTSD which do 
not necessarily target CPTSD symptoms. It was not possible to draw firm conclusions 
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regarding this hypothesis due to most participants not having finished Phase 3 at the 
time of analysis. 
 Of the four participants for whom there was data for the first half of 
individual treatment, all showed improvement on the PCL-5. However, there was no 
data for the second half of treatment, which may have shown a different pattern of 
change. Of these four participants, two also showed improvements in CPTSD 
symptoms and self-compassion for this first half of individual treatment, but the other 
two did not. One participant showed some deterioration in FCSRS scores in the first 
half of individual treatment, indicating decreased levels of self-compassion.  The 
findings from this part of the analysis suggested that Phase 3 may be more effective in 
reducing PTSD symptoms, as measured on the PCL-5, than CPTSD symptoms, 
supporting the hypothesis.  However, more data is needed for the latter part of Phase 3 
in order to fully explicate the changes that occur during this phase of the treatment.  
The finding that the first half of individual treatment appeared to be effective 
in reducing PTSD symptoms but less effective for CPTSD symptoms is important. If 
the same pattern of differential change continues in the second half of individual 
treatment and can be replicated in a larger sample, this would add weight to 
arguments that phase-based approaches are superior to individual trauma-focused 
therapy for people with CPTSD, as they are more able to address the extra ‘complex’ 
symptoms. This would provide empirical support for the ISTSS task force 
recommendations (Cloître et al., 2012) that individual trauma-focused therapy may 
not adequately address CPTSD symptoms. This contrasts with the position taken by 
de Jongh et al. (2016) in their recent critical analysis of the ISTSS guidelines, which 
is that phase-based treatments may not be necessary for this population.  
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The thematic analysis from this study lends weight to the arguments in favour 
of phase-based treatment. While several participants described the third phase as the 
most effective, a sub-theme of the data was that participants felt that all three phases 
were necessary. Further, several participants felt that Phase 3 was also the hardest 
phase, and that they would not have been able to cope with it had they not already 
done Phase 1 and Phase 2. Participants spoke about finding new coping strategies or 
reducing harmful behaviours, such as drinking, during these first two phases, which 
then enabled them to cope with moving on to addressing their traumas in the final 
phase.  Importantly, Phases 1 and 2 were also group-based, and a significant theme of 
the qualitative analysis was that the participants felt the group format itself offered 
benefits above individual treatment. A treatment consisting of individual trauma-
focused therapy only, as proposed by de Jongh et al. (2016), would therefore lack 
these advantages.  
Group Format 
The thematic analysis identified a range of perceived benefits from undergoing 
treatment in a group format. Participants spoke of group members providing 
additional support during sessions, in terms of comfort or encouragement, as well as 
social support outside and between sessions. They also spoke about how powerful the 
experience of being amongst people with shared experience of CPTSD could be; that 
it normalised their own symptoms and emotions, which in turn helped them to feel 
more ‘normal’ and less stigmatised. Therefore, treatment in a group appears to help to 
reduce the shame and stigma that are often features of PTSD (Lee, 2012). This 
suggests that phase-based treatments for CPTSD may benefit from incorporating at 
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least one group phase, unlike the individual format of the stabilization intervention 
STAIR-PE (Cloître et al., 2002).   
 However, another sub-theme of the thematic analysis was that the group 
format of the treatment was, for some participants, the main cause of anxiety prior to 
starting treatment. This is significant because it suggests that the format may impact 
on treatment uptake, despite the positive experiences that participants reported once 
they had actually started the group. This finding is consistent with a study of 
acceptability of group treatment for people with panic disorder and agoraphobia 
(Sharp, Power & Swanson, 2004), where participants were given a choice between the 
two formats for equivalent CBT treatment at the end of a waiting list period.  The 
study found that 95 per cent chose individual treatment over a group format. The 
authors then randomly allocated participants to either condition and found that 
outcomes were the same for participants in the two groups, suggesting the 
unpopularity of group treatment was not due to inferiority. In the current study, 15 of 
the 127 clients referred with CPTSD were judged at assessment to be unsuitable for 
the treatment programme because either they preferred not to be in a group, or their 
clinician considered them unsuitable for a group. This supports the possibility that a 
group format of treatment may somewhat reduce uptake of treatment.    
Strengths of Study 
This study used a mixed methods approach consisting of two analyses, a 
quantitative case series analysis and a qualitative thematic analysis. These were able 
to address two different research questions, the first about the effectiveness of the 
treatment and the second about its acceptability to service users. The findings of the 
case series suggested that the treatment was effective in reducing PTSD and CPTSD 
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symptoms, and the thematic analysis indicated that most participants experienced the 
treatment programme to be helpful and relevant to their difficulties. Whilst most 
existing studies of phase-based treatments have focused on effectiveness, a treatment 
with low acceptability may have implications for treatment uptake and adherence. The 
mixed-methods approach therefore allowed a triangulation of evidence that would not 
be possible with one method of analysis alone. Evaluating the treatment programme 
from the perspective of the service-user also reflects a growing recognition in UK 
health legislation of the importance of service-user feedback and involvement in the 
shaping of services and evaluation of care quality (Health and Social Care Act, 2008).   
The value of mixed method research in evaluating treatment interventions is 
increasingly being recognised. Dattilio, Edwards and Fishman (2010) argue that 
whilst Randomised Controlled Trials (RCTs) are generally seen as the gold standard 
of treatment effectiveness studies, case study designs and qualitative approaches offer 
a level of rich, contextual information as well as a degree of ecological validity that 
RCTs cannot. They propose that evaluations of psychotherapeutic treatments ought to 
always employ mixed methods, comprising qualitative interview-based explorations 
of the implementation of the treatment, as well as systematic case studies, and RCTs.  
The limitations of RCTs are inherent in their need for homogeneity in 
samples, which leads to exclusion of people with comorbid conditions, as well as the 
need for complete data which leads to exclusion of people with less reliable 
attendance. People with CPTSD often struggle with somatic conditions, emotional 
and interpersonal instability in their lives that may affect attendance. Additionally, 
they often have co-morbidities such as personality disorders, substance-use or self-
harm which are often used as exclusion criteria for RCTs. For example, one of the 
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few existing RCTs of phase-based treatment for CPTSD, conducted by Cloître et al. 
(2002), excluded people with any of the following: dissociative disorder, Bipolar I 
disorder, borderline personality disorder, or the presence of a suicide attempt or 
psychiatric hospitalisation within the last three months.  Criteria such as these mean 
that clinically-representative CPTSD populations may be under-represented in large-
scale, controlled research, whereas small n designs potentially allow a more inclusive 
analysis with greater applicability to naturalistic clinical settings. The present study 
included participants with recent risk, recent psychiatric hospitalization and a 
participant with a diagnosis of BPD.  
Additionally, using an idiographic approach to analysis meant that differences 
between participants were made visible that would have been lost through the 
‘averaging out’ of scores that occurs in a group level of analysis, thereby identifying 
some participants who experienced very great changes in symptoms, and a few who 
showed much less. Using repeated measures at a single case level also enabled a more 
detailed examination of change across phases that would not be possible with a large 
sample.  
Limitations  
The strengths of a small n, mixed methods design must also be weighed 
against the disadvantages of these approaches.   
Sampling. Most importantly, the findings of this study are not generalizable to 
the CPTSD population as a whole, and, as such, the case series can only describe the 
effectiveness of the treatment for the nine individual participants. In this case, the nine 
individuals were all female, predominantly White British, and middle-aged. The 
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sample of six for the thematic analysis was also predominantly female. That the 
participants for both analyses were mainly female reflected the higher numbers of 
female referrals for CPTSD at BTSS, and the fact that some male clients were waiting 
for an all-male CRG.  
Secondly, it is important to note the selection bias inherent in selecting to 
study the acceptability of the treatment to people who have completed the full 
programme. Since people who are unsatisfied with their treatment are less likely to 
complete it, the findings of the thematic analysis may be skewed towards presenting a 
positive picture of clients’ experiences of the treatment programme. A useful follow-
up study would be to interview clients who withdrew from treatment before 
completion, and analyse their responses in the same manner. 
The same selection bias affects the case series component of the study.  
Information about attrition from the point of assessment, presented in Chapter 2, 
revealed that some people who were assessed as having CPTSD decided not to do the 
full three-phase treatment, or refused treatment in a group format and were offered an 
individual alternative. Therefore, the final samples, both for the case series and the 
thematic analysis, consisting only of those who were enrolled in the full treatment, 
selects out those who did not do all three phases, and who might potentially have been 
less likely to benefit from the treatment, or less likely to find the treatment or group 
format acceptable if interviewed, than those who chose to do the full treatment. This 
may have skewed the outcome results toward successful outcomes. Further, all 
participants had to be available to do the full treatment which included groups held 
during working hours, which would have excluded some people with full-time jobs or 
caring commitments, and perhaps also those less-motivated for treatment.  
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Incomplete data.  The analyses that were carried out were not as planned in 
the original study design. Due to difficulties at the service in distributing correct 
measures, there was a limited sample of participants eligible for the case series, none 
of whom had completed treatment by the time of analysis. As a result, there were 
different samples for the case series and the thematic analysis, which meant that the 
findings of the case series could not be directly related to the findings of the thematic 
analysis. Using the same sample for both would have made it possible to use the 
interview data to understand more about possible reasons that specific participants 
benefited more in terms of symptom reduction than others. It could have also have 
enabled exploring whether those who showed little improvement on outcome 
measures found anything in the treatment that was beneficial to them.   
The same difficulty of case series participants not having completed treatment 
meant that there was incomplete Phase 3 data for four participants, no data Phase 3 for 
the majority, and no follow-up data. This meant that conclusions about the effects of 
individual trauma-focused therapy in the context of the treatment programme were 
highly tentative. However, Phase 3 comprises trauma-focused CBT or EMDR, both of 
which are well-evidenced for treating PTSD, whereas Phases 1 and 2 are innovative 
group interventions that have not been researched extensively, and therefore were of 
arguably greater importance to the evaluation.    
Case series design.  This study was a service-based evaluation and therefore 
the design of the case series analysis was directed by pre-existing service structures 
regarding administration of outcome measures.  As a result, the design fell short of 
‘Design standards’ for case series research which have been published by a panel of 
experts in single-case designs (Kratochwill et al., 2010). The main area of limitation 
132 
 
was the number of time points at which questionnaire measures were administered. 
This was partly due to the use of several full standardised measures such as the PCL-
5, PHQ-9 and GAD-7 at every data point, which meant that further increasing the 
number of data points would have put undue burden on participants. 
A particular issue was that there were only two pre-treatment data points, 
whereas the guidelines argue for a minimum of three per phase, including three before 
treatment in order to establish a baseline of symptoms. A good baseline phase in 
single case design acts as a ‘within-participant control’ in order to distinguish the 
possible effect of time on recovery from the effect of the intervention.  Some 
experimental studies with control groups have found that a proportion of participants 
recover spontaneously while waiting for treatment, for example, McDonagh et al.’s 
(2005) study of CSA survivors reported that 17.4 per cent of wait list controls no 
longer met PTSD criteria after 14 weeks.  Conversely, other studies of CPTSD or 
CSA populations have found no improvement in wait list conditions (e.g. Resick & 
Schnicke, 1992; Cloître, et al., 2002). Whilst it is problematic to make comparisons 
between findings from the current, small n study and larger studies, the rate of 
reliable, clinically-significant change in the current study greatly exceeds 
McDonagh’s reported 17.4 per cent rate of spontaneous recovery, making it less likely 
that all improvements in PCL-5 scores over the course of treatment in this study were 
attributable to spontaneous recovery.  
A second design limitation was that there were only two data points for Phase 
1, pre- and post-, whereas a minimum of three is again expected according to expert 
design standards. A consequence of having fewer data points was that the more 
sophisticated tools of visual analysis, for example, projecting from one phase to the 
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next, were inappropriate, as was the use of non-overlap statistics, which is advocated 
by some proponents of statistical analysis in case series designs (e.g., Kazdin, 2007; 
Shadish, 2014).  Relying on visual analysis of CPTSD and FCSRS without the 
addition of statistical analysis is considered acceptable and indeed preferred by some 
researchers (Morley, 1994); however it makes it difficult to identify reliable, 
significant change. Therefore, this study’s conclusions about the impact of the 
treatment on CPTSD symptoms or self-compassion are necessarily tentative.  
Had the study been designed without pre-existing service constraints, one 
solution would have been to use the full, standardised measures for pre-post analyses 
only, and to use a single target measure more frequently, as well as brief process 
variables, such as visual analogue scales, administered every session, providing more 
data points but each having a lower burden on participants (Morley, 1996). 
Measurement. A new measure, BTSS CPTSD (Billings & Whalley, 
Unpublished), was trialled in this study, consisting of four additional items in the 
format of the PCL-5, and intended to assess the additional CPTSD domains 
(emotional dysregulation, interpersonal difficulties, dissociation and somatic 
symptoms) that are not assessed by the PCL-5. This was necessitated by the absence 
of any purpose-designed, validated measure of CPTSD, which may be due to the 
current lack of formal diagnostic criteria for CPTSD.  
The Structured Interview of Disorders of Extreme Stress (SIDES; Pelcovitz et 
al., 1997) is the only purpose-designed measure for assessing DESNOS symptoms 
and has a self-report measure version, the SIDES-SR.  The SIDES and SIDES-SR 
have therefore been used by a few researchers (e.g. Dorrepaal et al., 2010; Maack, 
2012) to assess Complex PTSD. However, it is a long, 45-item measure which, as a 
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treatment outcome measure adds considerably to the burden on participants, and was 
therefore judged to be inappropriate for a repeated-measures design. Furthermore, to 
date, the SIDES has not been widely used, perhaps because DESNOS no longer exists 
as a diagnostic category since the introduction of DSM V, and as a result there is 
minimal evidence regarding its psychometric properties.  
Other researchers (e.g., Cloître et al, 2010) have used a combination of items 
from other measures to tap into the various constructs associated with Complex 
PTSD, using measures of depression, anxiety, and anger.  However, this too has 
drawbacks: the measures are not designed for the purpose and therefore their validity 
for measuring CPTSD is unestablished. Additionally, using scores on several different 
measures in sum as an indicator of CPTSD makes it less straightforward to identify 
cut-offs or norms, and again adds considerably to the burden on participants. 
The CPTSD BTSS measure was therefore employed as an economical solution 
to the problem of measuring CPTSD symptoms in the absence of a purpose-designed 
and well-validated measure of complex PTSD. However, further research is required 
to explore the statistical properties of the measure. Additionally, the five-point 
response scale, which was adopted for consistency with the PCL-5, arguably makes 
the individual items less sensitive to change, and more liable to be affected by floor 
and ceiling effects, and therefore less suitable for individual analysis.  
The lack of an agreed, formal diagnosis of CPTSD was also a difficulty for the 
application of the inclusion criteria for this study. Clinicians who assessed clients for 
PTSD with CPTSD features were doing so based on expert consensus guidelines 
regarding CPTSD, rather than on clear diagnostic criteria, which represents a threat to 
validity. Furthermore, due to service constraints it was not possible to have 
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participants assessed separately by two clinicians in order to establish whether or not 
there was agreement, indicating inter-rater reliability.  Therefore, this method of 
determining CPTSD in the sample does not have demonstrable validity or reliability. 
Finally, in regards to measuring PTSD, the use of the PCL-5 to establish 
severity and diagnostic status is reliant on participants’ self-report of symptoms, 
whereas the gold-standard for PTSD diagnosis is the Clinician Administered PTSD 
Scale (CAPS-V), a structured interview.  However, this was judged not to be feasible 
as an outcome measure for a repeated measures design due to the considerable added 
burden to participants.  
Future Research  
This was the first evaluation of this new, phase-based treatment programme, 
drawing on an exploratory, pragmatic research design using a small sample. Given 
that the findings have suggested a good level of effectiveness of the treatment 
programme for treatment of PTSD, some impact on CPTSD symptoms, as well as the 
acceptability of the treatment programme to service-users, there is now a good basis 
for continued clinical use of the treatment programme to treat people with CPTSD, 
coupled with further research. A logical first step would be to continue the current 
study to follow participants to post-treatment and through a follow-up period to 
investigate whether gains, particularly in CPTSD symptoms and self-compassion, 
about which very little is known, are consolidated or lost after the end of treatment.   
To build on this study, a useful next step would be to utilise an experimental 
design, where phases are administered in different orders, to explore whether the 
order has any impact on effectiveness. The structure of the current programme departs 
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somewhat from the ISTSS expert consensus recommendations.  The ISTSS 
recommendation is for a three-phase model where Phase 1 consists of establishing 
safety, strengthening the individual’s capacities for emotional regulation and reducing 
shame, Phase 2 consists of trauma-focused therapy, and Phase 3 consists of 
interventions designed to consolidate the gains in emotional, social and relational 
competencies, and to aid the transition out of therapy to greater engagement in 
community life (Cloître et al., 2012). However, these are guidelines and have not yet 
been tested empirically. It would therefore be important to investigate whether the 
order of the phases in this phase-based treatment programme has any impact on 
effectiveness or acceptability of the treatment.   
A further experimental manipulation that may be important is that of dose, 
since there is no research in this area to date and therefore the length of the treatment 
phases does not have an empirical basis. Since many participants showed 
deterioration in symptoms during the wait period between Phase 1 and 2, it would be 
interesting to manipulate the length of Phase 1 to see if this improves consolidation of 
gains. The ISTSS survey found that the majority of experts considered a combined 
treatment duration of 9 to 12 months for the first two phases to be suitable, which is 
longer than the current study, and longer than other existing phase-based treatments 
such as STAIR-PE, which consists of sixteen sessions in total (Cloître et al., 2002). 
Future research in this area will benefit greatly from a reliable, validated 
measure of CPTSD, and therefore more research is needed to establish the statistical 
properties of BTSS-CPTSD.  A pre-requisite of larger-scale research will be the 
identification of sufficiently sensitive, validated measure(s) with which to measure 
change in CPTSD symptoms, as well as sufficient numbers of people who have 
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completed the full treatment for recruitment. Once these have been achieved, there 
would be a strong case for an RCT in order to provide evidence of the efficacy of the 
treatment programme.  
An RCT to evaluate the treatment programme would benefit from a 
comparison group of participants who only do Phase 3, individual trauma-focused 
therapy, in order to directly compare the efficacy of these two approaches, and 
thereby address the main concern of de Jongh et al. (2016), that the need for phase-
based treatment above single-phase treatment is still unproven.  This larger scale of 
research can also explore factors that may mediate the efficacy of the treatment, such 
as category of trauma, chronicity of trauma and demographic variables, in order to be 
able to make recommendations as to whom the treatment is most likely work for.  
Clinical Implications  
The current study clearly has a high level of relevance to clinicians working in 
the areas of PTSD and CPTSD.  With further quantitative research to establish the 
efficacy of the treatment programme, the protocol for this phase-based treatment 
programme may be shared with other services in order broaden the availability of this 
treatment for people presenting to services with CPTSD.   
The findings of the thematic analysis have raised a couple of areas for 
clinicians to consider in the development of this treatment programme. Firstly, the 
anticipatory anxiety generated by group format treatments is significant, and may 
result in lower uptake of treatment. The potential risk of reducing uptake must of 
course be balanced against the service-level benefits of offering group-format 
treatments, by enabling more service users to access treatment sooner.  In order to 
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mitigate the risk of the group format reducing uptake, particular care will need to be 
given to communicating to clients the advantages of group format treatment over 
individual treatment, as richly demonstrated by the thematic analysis.  It will also be 
worth emphasising to potential clients the clear boundaries put around personal 
disclosure within the groups. There is also, however, a need for an alternative to 
group treatments for those who cannot be convinced, and would otherwise not access 
treatment at all. 
Secondly, the thematic analysis indicated that wait periods between treatment 
phases were an important issue to participants, with shorter waits described as better, 
as they were seen as reducing the risk of forgetting earlier treatments, as well as 
limiting the build-up of anxiety for the next phase, particularly in relation to the wait 
for trauma-focused therapy. Where services are unable to offer shorter wait periods, 
there may need to be consideration given to optional ‘holding groups’ for those who 
are between phases, in the same way that some services offer holding groups for 
waiting list clients.  
 
Conclusion  
 This study has explored the effectiveness and the acceptability of a new, 
phase-based treatment programme for CPTSD, which incorporates a unique 
compassion-focused group component, in addition to psychoeducation, as a form of 
stabilisation prior to individual trauma-focused therapy. This ambitious programme 
seeks to address the needs of people who present with a broader spectrum of 
difficulties than is typically seen in sufferers of PTSD to single-incident traumas, 
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some of which may interfere with help-seeking or adherence to treatment.  This study, 
whilst tentative in its findings, tends to support the ISTSS expert guidelines which 
argue that the phase-based approach may have advantages for this population that go 
beyond the benefits of individual trauma-focused therapy.   
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